hg_47337.1

Basic information about the TSS

---

TSS ID: hg_47337.1 Species: human Chr: chr4		Start: 38664189 End: 38664206 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000514033.1 ENST00000261438.10 AK313459 BC051687 BC030662 Distance: 0 GeneID: 51274 HGNC/MGI_ID: HGNC:16516 UniProt_ID: B2R8P9 P57682

Gene_name: Kruppel like factor 3 Gene_symbol: KLF3 Gene_synonyms: BKLF Gene_source: HGNC:16516

TATA-Box annotation

---

Distance to TSS:	-1
Nearest PromoterID:	NM_016531
Entrez ID:	51274
Nearest Unigene:	Hs.298658
Nearest Refseq:	NM_016531
Nearest Ensembl:	ENSG00000109787
Gene Name:	Kruppel like factor 3
Gene Alias:	BKLF
Gene Description:	Kruppel like factor 3
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.781095
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@KLF3 p2@KLF3 p3@KLF3 p4@KLF3 p5@KLF3 p6@KLF3 p7@KLF3 p9@KLF3 p10@KLF3
Sample		p1@KLF3	p2@KLF3	p3@KLF3	p4@KLF3	p5@KLF3	p6@KLF3	p7@KLF3	p9@KLF3	p10@KLF3
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	8.18	2.73	0.00	1.56	0.19	0.97	0.19	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	10.32	5.66	0.00	1.42	1.01	1.42	0.00	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	7.91	5.79	0.19	0.39	0.96	0.77	0.19	0.19	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	7.90	4.57	0.83	1.25	0.00	0.62	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	7.87	4.27	0.45	0.45	0.22	0.67	0.00	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.92	3.29	0.19	0.00	0.58	1.16	0.00	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	6.32	2.83	1.31	0.44	0.65	0.22	0.22	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	3.15	2.42	0.48	1.70	0.48	0.48	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.20	3.42	0.43	1.50	0.64	1.07	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	5.80	3.48	1.16	1.16	0.00	0.00	0.00	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	7.28	2.02	2.02	0.81	0.00	0.40	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.54	2.03	1.63	3.66	0.00	2.03	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	5.32	5.16	5.64	2.58	0.81	0.48	0.97	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	3.46	4.21	3.01	1.65	0.75	0.45	0.45	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	3.29	2.63	5.05	3.07	0.00	0.22	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.04	4.02	3.02	2.01	0.75	0.25	0.50	0.00	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	3.06	3.28	3.71	1.31	1.09	0.22	0.44	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	4.22	2.95	2.95	0.84	0.00	0.42	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	4.27	7.46	1.07	1.07	0.53	1.07	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.22	2.11	3.61	3.16	0.60	0.30	0.45	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	5.08	4.28	4.28	2.27	0.40	0.67	0.67	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	7.94	8.11	5.01	3.11	1.04	1.21	0.52	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	6.72	6.08	5.43	3.62	0.39	0.52	0.78	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.49	4.85	6.31	2.91	0.24	1.21	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.35	7.74	8.51	3.10	0.52	0.26	1.03	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	9.18	5.70	6.65	3.17	1.58	0.63	0.63	0.63	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	13.19	5.49	6.04	2.75	0.00	0.00	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	10.37	7.54	5.42	5.19	0.94	0.71	0.47	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.18	5.17	7.11	3.39	0.16	1.13	0.48	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.96	6.15	6.33	2.90	0.36	0.72	0.36	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	5.86	5.44	5.65	2.93	0.63	0.63	0.42	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	7.82	6.45	4.88	2.15	0.39	0.59	0.20	0.20	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	6.33	5.28	3.80	1.48	0.42	0.42	0.63	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	4.29	4.45	2.31	0.99	0.49	0.33	0.49	0.16	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	5.42	3.74	3.37	1.68	0.93	0.00	0.37	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	4.02	3.83	4.22	1.72	0.38	0.77	0.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	4.70	3.27	2.66	0.61	1.02	0.82	0.61	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	5.64	2.82	1.01	1.01	0.20	0.81	0.40	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	5.40	2.43	1.89	0.27	0.81	0.54	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	5.28	4.08	1.20	1.44	0.48	0.72	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	2.82	3.76	2.35	0.94	1.18	1.18	0.00	0.24	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	3.95	2.93	1.17	0.73	0.88	0.15	0.15	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.22	5.27	2.74	1.27	1.69	0.63	0.21	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.69	6.99	1.75	2.10	0.52	0.17	0.52	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.03	6.42	3.01	1.20	0.80	0.60	0.00	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	10.93	7.44	3.02	1.16	1.16	0.70	0.47	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	8.88	3.36	0.72	1.20	1.20	0.48	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.07	7.15	3.58	2.09	1.19	0.89	1.19	0.00	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	5.98	8.86	0.96	1.20	1.91	1.44	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	6.67	5.46	1.62	1.01	1.21	0.00	0.61	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.45	6.97	2.05	1.43	0.41	1.43	1.02	0.00	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.12	4.00	2.45	1.56	0.00	0.67	0.67	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	6.74	6.03	1.42	1.06	0.71	1.06	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	5.96	5.30	1.99	2.32	0.99	0.00	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	2.52	3.36	0.84	0.84	0.00	0.84	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	4.59	5.05	0.92	0.00	0.46	0.46	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.05	8.10	3.24	0.65	1.62	0.97	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	5.78	5.46	2.25	0.96	0.64	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	7.86	5.03	0.94	0.63	1.89	0.31	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	5.64	1.41	0.71	0.71	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	6.17	6.17	3.93	0.56	2.80	0.56	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	7.17	9.55	0.80	2.39	0.00	0.80	0.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.49	7.81	1.36	0.68	1.36	0.00	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.00	6.17	4.87	2.60	1.62	0.65	1.62	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	10.29	8.87	1.06	1.42	0.35	0.00	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	0.00	0.00	0.00	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	6.34	2.93	1.46	0.98	1.46	0.00	0.49	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	4.96	2.98	1.49	1.49	0.50	0.00	0.50	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	5.16	4.69	0.94	1.88	0.94	0.47	0.47	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.29	3.64	0.99	0.99	0.99	0.66	0.66	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.64	6.19	2.17	1.24	0.31	1.24	0.00	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	5.50	3.67	1.22	0.31	0.61	0.00	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	7.60	3.17	6.34	2.06	0.48	0.32	0.16	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	6.58	2.73	4.65	1.60	0.16	0.32	0.00	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	10.31	5.34	6.11	0.89	0.38	0.38	0.25	0.64	0.13
Adipocyte - omental, donor2	11474-119C7	3.74	1.49	1.49	0.00	0.75	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	2.01	2.68	3.68	2.34	0.33	0.33	0.67	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	3.83	2.55	5.74	1.28	0.00	0.00	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	1.10	0.00	1.10	1.10	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.42	2.26	1.35	1.35	0.90	0.45	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	3.48	8.52	2.26	0.70	0.70	0.35	1.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	31.29	12.13	7.24	5.28	2.15	1.17	0.39	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	10.55	6.95	4.12	2.57	0.26	0.51	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	25.09	10.87	6.13	2.79	0.56	1.39	0.56	0.28	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	9.99	6.47	2.35	0.59	1.76	1.18	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	52.52	11.98	12.63	7.08	0.88	1.21	0.24	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	22.59	7.75	8.07	1.94	0.65	1.61	0.00	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	14.40	5.33	4.27	2.67	0.53	0.00	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	5.56	8.90	1.11	0.56	1.11	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	13.31	4.99	9.15	1.25	0.00	0.83	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	19.59	5.78	6.03	2.76	0.25	1.26	1.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	20.62	8.51	5.24	1.96	0.00	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	15.83	4.26	5.18	2.74	0.00	0.30	0.00	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	8.18	3.54	0.44	0.22	0.22	0.00	0.44	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	5.74	1.08	1.08	0.00	0.72	1.08	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	2.40	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.87	10.25	0.72	1.08	1.08	0.36	0.72	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	5.02	6.69	0.00	1.67	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	11.92	8.83	1.03	1.23	0.41	0.41	0.41	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	8.81	5.61	2.98	1.37	0.80	0.80	0.92	0.11	0.34
Anulus Pulposus Cell, donor2	11463-119B5	4.90	4.16	4.65	3.43	0.73	0.24	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.07	9.44	0.90	0.90	0.90	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.52	10.42	1.30	1.74	0.87	0.87	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	6.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	19.43	6.28	1.49	0.60	0.00	0.90	0.00	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	22.76	6.32	0.00	3.79	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	3.96	1.32	0.66	0.66	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.49	7.15	1.62	0.32	0.65	0.32	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.30	5.34	2.43	2.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	6.53	0.59	0.59	0.59	0.00	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.82	9.42	1.51	3.01	0.00	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.96	7.26	0.00	1.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	15.05	1.25	1.25	5.02	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	29.16	8.90	2.64	1.48	0.49	0.82	0.49	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	19.11	8.19	2.73	0.00	0.00	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	27.90	6.18	2.41	1.36	0.15	0.45	0.00	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	11.79	1.61	0.54	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.77	10.01	3.21	3.21	0.38	0.00	0.19	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	33.14	11.49	2.67	0.80	0.00	0.00	0.53	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	4.88	2.93	1.95	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.08	5.47	2.32	2.16	0.33	0.83	1.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	8.41	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	18.87	6.69	2.23	2.06	0.51	0.86	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	14.08	5.83	0.49	0.00	0.00	0.97	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.42	8.35	0.76	3.42	0.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	8.48	0.00	0.00	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	7.41	0.00	0.57	0.57	1.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	16.46	5.13	2.99	1.71	0.43	0.64	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	19.61	5.42	1.81	1.03	0.52	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	8.91	1.88	0.94	0.47	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.12	8.04	3.22	2.25	0.32	0.32	0.32	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	2.85	1.43	2.14	0.00	0.71	1.43	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	5.85	3.51	1.17	0.58	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	16.26	7.23	2.11	2.41	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	20.20	1.19	3.56	0.00	0.00	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.78	9.66	2.54	1.02	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	22.67	7.13	2.80	2.80	0.51	0.25	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	18.43	5.08	2.54	1.91	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	21.15	9.93	1.73	2.16	0.43	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.17	8.89	2.12	1.48	1.06	0.42	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.88	7.83	2.03	2.03	0.00	0.29	0.58	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	3.78	2.83	3.78	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.56	6.95	2.03	2.20	0.34	0.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	6.95	4.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	61.26	4.23	8.45	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	42.02	10.29	3.86	3.22	0.43	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	39.11	8.42	2.41	1.20	0.00	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	8.75	4.37	2.19	0.00	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.53	6.21	2.76	1.61	0.46	0.92	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	5.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.46	5.59	2.29	0.51	0.25	0.25	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	19.61	6.61	3.72	1.24	0.83	1.03	0.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.17	5.81	2.75	1.53	0.00	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	17.21	10.52	4.78	0.00	0.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	25.28	9.31	3.55	1.77	0.67	0.44	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	7.63	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	21.05	8.31	1.11	0.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.54	7.41	2.12	2.12	0.26	0.26	0.00	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.81	6.91	2.54	1.45	0.36	0.00	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	3.56	7.49	2.70	1.11	1.11	1.35	0.61	0.25	0.37
Astrocyte - cerebellum, donor2	11580-120F5	3.25	4.79	3.77	1.20	1.37	0.51	0.86	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	2.73	3.78	1.26	0.21	1.89	0.42	0.84	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	16.38	6.62	4.88	1.74	1.39	1.39	1.05	0.00	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	16.02	8.09	3.24	1.94	1.29	1.13	0.65	0.16	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	12.38	5.82	5.67	2.98	1.79	1.34	0.60	0.15	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	1.03	1.03	0.23	0.34	0.23	0.34	0.23	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	1.13	1.38	0.13	0.50	0.75	0.38	0.13	0.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	1.82	1.02	0.57	0.11	0.23	0.23	0.23	0.00	0.23
Basophils, donor1	12241-129G9	108.27	124.49	4.18	8.11	4.71	1.83	6.54	0.26	1.57
Basophils, donor2	12242-129H1	162.00	113.65	2.16	9.74	5.05	1.08	8.30	0.00	0.72
Basophils, donor3	12243-129H2	111.13	119.95	3.82	12.49	7.50	2.50	3.53	0.15	1.76
Bronchial Epithelial Cell, donor1	11511-119G8	19.19	4.10	2.59	1.29	0.22	0.22	0.65	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.94	6.86	0.91	0.00	0.91	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	2.51	4.39	1.26	0.00	0.63	0.63	1.26	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	4.37	3.95	0.42	2.08	0.21	0.42	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	11.51	8.29	1.15	1.38	0.23	0.23	1.15	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	9.90	5.04	0.72	2.16	0.90	0.54	0.00	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.43	0.70	0.00	0.47	1.40	0.47	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.46	30.70	2.56	5.76	5.76	1.92	3.20	0.00	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	103.42	31.03	10.34	20.68	20.68	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	59.74	81.15	1.69	3.94	5.07	2.25	3.38	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	73.50	119.71	2.60	2.97	4.08	2.23	2.23	0.00	1.48
CD14+ Monocytes, donor3	11381-118B4	72.23	87.60	2.63	6.37	6.37	1.98	3.07	0.00	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	25.47	9.34	4.53	2.55	2.55	0.28	3.40	0.28	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	18.95	12.89	3.79	5.31	2.65	1.52	2.27	0.00	1.14
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	27.94	10.52	8.55	5.92	3.29	1.64	1.97	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	29.92	33.97	4.48	1.88	3.47	3.90	2.60	0.14	1.88
CD14+ monocytes - mock treated, donor2	11873-125C1	25.04	22.93	1.21	2.11	3.32	5.13	3.62	0.00	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	30.80	43.35	2.84	2.37	3.32	4.50	2.13	0.00	2.84
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.74	22.10	1.17	0.67	3.52	2.51	1.34	0.00	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.63	20.98	2.21	1.66	2.48	1.66	0.83	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	19.34	30.50	0.25	0.99	2.73	1.98	1.24	0.00	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	21.73	19.58	0.59	1.17	1.76	2.15	2.35	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	18.16	26.17	0.89	0.53	4.63	3.03	1.25	0.36	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.59	30.03	0.44	2.61	1.52	1.52	0.65	0.00	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	24.12	30.67	1.64	1.17	1.40	2.11	2.11	0.00	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	24.82	44.88	1.58	2.11	3.17	1.58	1.58	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	34.39	0.00	2.22	1.11	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	19.49	29.15	2.38	1.04	1.19	2.83	1.93	0.00	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.78	15.76	0.80	1.00	2.00	4.59	0.80	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	15.61	16.03	0.83	1.67	1.04	1.87	1.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	13.73	18.07	1.60	0.23	2.75	1.14	1.37	0.23	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.23	14.25	0.45	0.90	1.36	2.04	1.13	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.59	23.57	0.44	0.87	0.87	2.62	0.87	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.55	30.93	2.15	0.54	3.50	3.50	1.34	0.00	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	30.71	36.46	2.09	2.09	3.31	5.58	1.74	0.00	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	29.88	42.08	1.68	0.84	4.21	5.89	3.37	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.35	13.41	0.37	0.55	1.29	1.84	0.92	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.75	13.74	0.70	0.35	1.41	5.99	0.70	0.00	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.36	12.28	0.00	0.88	0.00	0.88	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	20.58	28.42	1.74	0.70	2.96	3.66	2.44	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	26.76	37.54	0.00	1.49	3.35	3.72	1.86	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	35.35	38.15	1.08	2.16	1.51	1.72	1.08	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	14.74	14.33	2.05	0.82	0.41	2.46	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	14.14	12.75	0.46	0.46	0.46	2.32	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	15.31	12.76	0.23	0.70	0.70	0.46	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	111.82	60.81	4.58	8.94	2.18	0.44	1.53	0.00	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	99.10	68.61	3.23	7.85	1.85	1.62	1.62	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	72.57	52.64	3.47	8.45	2.17	0.65	0.87	0.00	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	76.77	87.67	3.11	3.27	3.43	1.71	4.05	0.00	1.71
CD14+CD16- Monocytes, donor2	11799-124C8	55.19	71.25	3.32	2.97	2.97	2.79	4.54	0.35	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	97.66	105.24	3.57	7.36	6.02	3.57	6.47	0.00	3.57
CD14-CD16+ Monocytes, donor1	11790-124B8	181.17	71.45	5.87	9.44	2.04	0.51	1.02	0.00	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	152.60	74.43	6.81	12.73	2.85	0.44	2.85	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	124.85	72.43	4.84	11.37	2.32	0.84	1.47	0.00	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	26.42	28.45	0.00	2.03	4.06	2.03	10.16	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	34.58	36.61	2.03	0.68	5.42	1.36	4.07	0.00	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	26.93	48.67	0.00	0.00	6.21	0.00	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	28.78	36.78	0.00	0.00	3.20	0.00	3.20	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	27.88	43.96	1.61	0.00	5.90	0.00	5.36	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	44.22	0.00	0.70	2.11	0.00	2.81	0.00	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	37.65	47.06	0.00	0.78	3.92	0.78	7.06	0.00	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	38.23	42.19	0.00	1.32	3.95	3.95	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	40.27	92.05	4.11	0.00	5.75	4.11	0.82	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	73.99	124.77	2.18	2.90	5.80	4.35	2.18	0.00	2.18
CD19+ B Cells, donor3	11705-123B4	50.99	107.02	0.50	2.52	8.08	5.55	1.01	0.00	4.54
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	353.55	163.24	24.65	21.42	7.27	4.85	5.25	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	274.85	127.44	21.57	13.18	3.60	1.60	2.00	0.80	1.20
CD34+ Progenitors, donor1	11545-120B6	51.21	62.25	3.01	6.02	4.02	3.01	3.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	50.00	65.73	3.37	3.93	5.62	3.37	2.81	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	25.55	18.04	2.25	5.26	2.25	1.13	1.13	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	26.61	24.35	1.58	1.35	2.03	1.58	1.58	0.00	1.35
CD4+ T Cells, donor1	11225-116C1	189.95	247.44	4.28	8.57	16.42	11.43	4.28	0.71	1.79
CD4+ T Cells, donor2	11306-117C1	154.93	213.10	4.29	9.19	12.86	5.51	4.29	0.00	4.29
CD4+ T Cells, donor3	11382-118B5	201.91	240.64	6.10	8.84	9.15	7.93	5.49	0.61	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	88.82	67.13	2.55	3.32	3.06	1.53	2.30	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	120.16	80.41	3.37	4.49	1.80	3.37	2.92	0.00	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	97.45	73.59	2.01	2.01	1.72	2.01	2.30	0.00	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	329.97	266.91	3.32	7.11	17.07	7.11	6.64	0.00	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	241.60	254.94	2.11	4.92	16.15	8.43	7.73	0.00	5.62
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	168.11	207.66	0.00	9.89	6.59	0.00	9.89	0.00	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	33.67	21.97	0.29	1.45	1.45	1.16	1.59	0.14	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	55.24	36.27	1.53	3.05	0.85	0.85	2.03	0.17	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	58.36	38.53	1.93	4.19	1.13	1.13	1.29	0.00	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	166.32	135.83	3.59	3.14	5.83	3.14	2.69	0.45	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	164.91	181.33	1.75	4.19	6.64	2.80	4.19	0.35	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	131.11	122.75	2.20	2.64	4.84	2.20	2.20	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	20.66	24.46	0.42	0.42	0.42	0.00	0.84	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.26	9.97	0.42	0.62	1.04	0.42	1.04	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.68	7.68	0.67	0.33	0.00	0.67	1.00	0.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	267.86	249.36	4.62	5.71	9.25	8.97	8.43	0.00	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	258.86	299.60	3.75	10.72	17.15	9.11	11.25	0.54	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	181.12	242.09	8.97	1.79	7.17	3.59	3.59	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	25.03	22.07	0.56	0.93	1.85	1.85	2.04	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	26.64	24.91	0.00	1.30	1.73	1.30	1.30	0.00	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	16.81	17.44	0.21	0.63	2.94	0.84	1.47	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	159.27	147.13	4.55	4.55	11.63	2.02	3.54	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	149.90	156.40	3.47	3.90	9.10	5.20	9.10	0.00	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	140.33	158.64	3.49	5.67	6.97	2.61	5.23	0.00	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	94.03	102.93	1.48	2.47	10.89	2.97	5.44	0.00	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	79.39	84.01	2.77	7.39	4.62	0.92	4.62	0.00	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	75.37	71.19	2.79	0.00	5.58	2.79	11.17	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	71.45	161.17	1.11	3.60	7.75	5.54	7.48	0.00	2.77
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	83.19	161.96	1.47	2.70	11.78	4.42	6.13	0.00	3.68
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	100.10	115.50	3.08	3.08	3.08	0.00	4.62	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	111.02	103.50	2.86	3.22	8.59	6.09	5.37	0.00	3.22
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	91.41	96.95	0.00	1.38	2.77	2.77	9.69	0.00	4.15
CD8+ T Cells, donor1	11226-116C2	216.08	215.10	1.64	6.22	10.80	4.58	8.84	0.00	2.62
CD8+ T Cells, donor2	11307-117C2	186.59	212.87	2.63	8.63	4.88	5.26	3.00	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	185.33	208.56	3.79	8.58	11.36	4.80	5.05	0.50	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	5.28	4.13	0.23	0.46	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.47	4.79	0.48	0.00	0.00	0.24	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	5.20	2.46	0.27	0.82	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	5.70	2.70	0.60	0.60	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	5.76	2.64	0.48	0.48	0.24	0.00	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	7.05	2.73	1.14	0.23	0.23	0.68	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.17	5.21	0.43	0.43	0.22	0.00	0.00	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	10.00	3.68	0.79	0.26	0.00	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	10.55	7.27	0.70	1.41	0.23	0.00	0.23	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	8.45	4.53	1.51	0.91	0.30	0.60	0.00	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.97	3.78	0.87	0.58	0.00	0.29	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.12	5.06	0.00	0.80	0.00	0.00	0.00	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	52.97	10.07	2.63	2.63	0.44	0.88	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	45.09	6.38	2.28	3.19	0.00	0.46	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	54.45	9.70	3.73	2.98	0.00	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	9.36	4.32	1.08	0.00	0.00	0.00	0.36	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	8.34	4.32	0.58	0.58	0.29	0.00	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	9.66	3.06	1.41	0.47	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	18.70	3.17	1.90	1.27	0.00	0.95	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	15.69	6.15	3.08	0.92	0.62	0.92	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.75	3.85	2.89	0.64	0.00	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	13.00	3.44	1.91	0.38	0.00	0.00	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.85	5.91	1.18	1.97	0.00	0.39	0.39	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	9.08	3.03	0.76	1.51	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	73.87	12.04	8.83	1.61	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	61.55	15.39	2.10	3.50	0.70	1.40	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	74.13	15.03	9.02	5.01	3.01	2.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	7.31	3.66	5.48	3.66	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	4.45	2.96	1.48	0.49	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	9.47	4.21	2.53	2.42	0.53	0.42	0.21	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	6.59	7.28	3.47	2.08	0.35	0.69	0.69	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	3.55	4.62	3.20	0.36	1.07	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	7.85	4.66	6.37	1.71	0.34	0.34	0.11	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	17.91	11.64	6.27	0.00	0.00	0.90	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.37	8.09	10.51	3.24	1.62	0.81	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	16.53	13.20	3.44	2.52	2.18	1.15	1.15	0.11	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	7.05	6.63	1.28	1.71	0.43	0.43	0.43	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	12.48	6.19	2.57	2.65	1.42	0.62	0.71	0.00	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	21.37	10.82	7.79	4.22	4.03	1.47	1.28	0.28	0.55
Corneal Epithelial Cells, donor1	11526-119I5	10.54	4.61	1.32	0.44	0.22	0.44	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	6.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	16.87	7.16	1.79	1.02	1.02	0.00	0.26	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	14.03	6.93	1.49	0.99	0.33	0.17	0.50	0.00	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	14.82	5.36	1.58	1.58	1.26	0.32	0.32	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	4.10	3.13	0.76	0.86	0.65	0.22	0.43	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	36.56	59.79	1.71	7.17	6.83	2.73	3.42	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	39.83	1.96	4.57	2.61	1.31	3.26	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	23.71	74.53	2.42	7.26	6.78	2.90	4.84	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	18.18	3.50	1.00	1.33	0.67	0.17	0.33	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	6.45	2.93	1.76	1.17	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	21.21	6.50	2.55	1.98	0.57	0.28	0.57	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	3.15	1.18	1.57	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	8.14	2.62	1.16	2.91	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	18.12	7.53	2.12	1.65	0.71	0.00	0.71	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	18.41	5.43	1.40	2.10	0.35	0.35	0.35	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	25.27	5.32	3.55	1.99	0.44	1.33	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	31.64	10.65	3.35	6.39	0.30	0.61	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	55.82	12.69	7.05	5.92	1.41	1.97	0.28	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	16.05	5.65	2.38	2.97	0.89	0.89	1.19	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	5.73	1.56	0.00	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	31.19	8.37	2.41	2.98	0.71	0.57	0.43	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	15.60	9.20	2.40	1.60	0.80	0.80	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.43	1.57	1.05	1.57	0.00	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	37.27	13.29	3.85	3.35	1.62	1.12	0.87	0.00	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.29	11.73	3.26	4.78	0.87	0.43	1.09	0.22	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	26.01	12.95	2.56	3.30	1.22	1.47	1.10	0.00	0.61
Endothelial Cells - Vein, donor1	11267-116G7	13.65	5.69	1.14	1.14	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	4.19	0.70	0.00	0.00	1.40	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	14.76	4.40	0.94	2.83	0.47	0.31	0.47	0.00	0.16
Eosinophils, donor1	12244-129H3	259.20	60.99	15.25	15.25	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	392.76	511.58	8.25	19.80	28.05	23.10	13.20	0.00	16.50
Eosinophils, donor3	12246-129H5	160.51	210.44	0.00	7.13	28.53	10.70	3.57	3.57	10.70
Esophageal Epithelial Cells, donor1	11507-119G4	8.31	2.93	1.22	1.22	0.73	0.00	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	8.32	2.08	8.32	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	9.85	2.87	0.82	0.82	0.41	0.41	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.36	0.99	1.53	0.55	0.00	0.00	0.00	0.11	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	14.08	4.44	3.79	1.08	0.54	0.22	0.54	0.00	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	9.70	5.22	2.91	0.61	0.24	0.36	0.49	0.12	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	30.30	4.91	8.60	4.50	0.41	0.27	0.14	0.14	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.40	6.01	4.32	2.64	0.21	0.11	0.32	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	14.49	11.86	9.49	5.01	0.53	0.26	1.32	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.60	9.63	4.32	4.98	0.00	0.66	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	4.99	3.63	1.81	1.36	1.81	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	3.79	0.76	3.79	0.76	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.47	3.94	1.73	1.42	0.16	0.00	0.47	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	23.04	10.91	10.31	6.97	0.91	0.61	1.82	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	10.41	7.49	4.95	3.05	1.02	0.51	1.27	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	15.16	5.91	3.03	3.49	0.76	0.15	0.45	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	4.02	5.63	3.48	1.88	0.80	0.94	1.21	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	5.61	3.88	2.59	1.73	0.00	0.43	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	2.93	8.79	1.46	1.46	0.00	2.93	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	9.46	10.61	3.00	1.38	1.61	0.23	0.69	0.00	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	11.02	12.21	8.14	1.70	0.68	0.85	2.37	0.17	0.34
Fibroblast - Dermal, donor1	11269-116G9	3.99	5.87	1.17	1.41	0.70	0.00	0.47	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	3.77	4.72	1.42	0.47	0.47	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	5.08	4.71	1.33	1.69	1.21	0.60	0.60	0.00	0.48
Fibroblast - Dermal, donor4	11450-119A1	7.46	8.59	2.15	2.60	0.90	0.23	1.13	0.00	0.34
Fibroblast - Dermal, donor5	11454-119A5	4.36	8.20	0.52	2.09	0.35	0.35	1.22	0.00	0.87
Fibroblast - Dermal, donor6	11458-119A9	5.68	13.81	1.30	2.27	0.81	0.49	1.62	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	8.12	4.79	0.83	1.25	0.83	0.42	0.83	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.77	7.34	2.88	1.57	0.52	0.52	0.26	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	6.33	6.98	1.32	1.32	0.79	0.53	1.32	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	9.57	8.70	4.06	2.51	1.64	1.06	1.45	0.19	0.58
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	8.31	7.27	1.04	3.12	1.04	3.12	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.34	4.58	3.88	1.06	0.53	0.35	0.00	0.00	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	6.70	6.70	1.56	0.78	1.09	0.16	0.16	0.00	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	6.22	7.30	0.95	1.08	0.41	0.14	0.27	0.00	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.06	6.70	0.00	1.41	0.35	0.71	0.35	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	11.26	6.58	0.73	1.17	0.58	0.29	0.73	0.00	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	10.50	9.27	1.36	1.36	0.00	0.14	0.55	0.27	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.65	11.63	2.52	1.76	1.21	0.22	0.55	0.00	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	18.20	9.98	6.60	3.23	0.59	0.29	1.32	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	2.72	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	16.41	5.97	2.98	2.98	0.00	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	8.23	8.02	2.32	1.06	1.69	0.42	0.63	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	4.17	8.33	2.50	1.67	0.00	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	2.80	1.40	2.80	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.68	1.40	0.84	0.00	0.28	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	8.12	9.34	0.81	2.03	2.44	0.81	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	7.99	3.99	0.00	0.00	0.00	0.00	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	0.00	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	11.06	6.79	1.36	0.58	1.16	0.58	1.16	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	12.89	10.92	1.82	1.52	1.82	0.91	1.37	0.15	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	15.91	10.40	3.06	2.75	0.61	0.00	0.92	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	6.11	5.34	2.29	1.14	0.38	0.38	0.38	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	5.40	3.51	2.43	1.62	0.54	0.00	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	10.32	4.99	4.87	2.55	1.16	0.58	0.35	0.00	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.14	5.53	1.99	1.33	0.88	0.55	0.55	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.11	5.89	0.81	1.02	1.02	0.00	1.02	0.20	0.81
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.68	3.34	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	7.91	5.93	0.79	1.58	0.79	0.79	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.91	15.28	3.57	1.79	0.99	0.40	1.39	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	6.57	5.15	3.20	0.89	0.71	0.36	0.18	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.42	7.10	4.14	1.38	0.79	0.39	0.20	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.22	4.81	2.41	2.71	0.60	0.90	0.90	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	5.29	8.31	2.48	1.19	1.19	0.54	0.86	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.36	11.89	3.29	5.57	0.51	0.25	1.01	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	10.67	6.23	1.80	1.15	1.31	0.16	0.66	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.27	8.02	7.62	7.62	0.60	0.00	1.00	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	9.64	9.54	4.52	2.01	0.80	0.60	0.80	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.07	11.49	3.32	4.23	1.21	0.60	0.60	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	11.35	6.88	2.90	1.49	0.58	0.66	1.08	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	8.03	13.33	5.98	3.25	1.03	0.34	0.85	0.34	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.57	5.91	1.97	1.97	0.33	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	4.90	7.78	1.92	0.96	0.96	0.11	0.21	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	8.43	3.88	1.01	1.35	1.01	0.51	0.34	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.27	3.14	0.78	0.94	0.47	0.16	0.31	0.16	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	59.26	23.53	11.33	16.56	0.00	0.00	0.87	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.80	5.20	1.39	0.87	0.52	0.17	0.87	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	25.50	7.03	0.52	1.56	0.00	0.00	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.34	8.94	1.28	1.28	1.02	0.26	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	2.30	2.30	3.06	0.77	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	4.47	4.47	0.64	0.64	0.00	0.64	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	9.70	3.14	3.42	5.13	0.29	1.14	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	16.27	5.79	3.58	6.07	1.93	0.55	0.55	0.55	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	30.14	9.59	4.11	5.25	1.37	2.28	0.68	0.23	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.92	5.75	2.97	5.35	1.59	0.99	0.40	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.27	4.49	4.23	4.49	1.32	0.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.96	14.35	4.89	5.54	2.28	2.61	0.65	0.33	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.52	4.86	4.86	3.10	0.00	0.88	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	7.91	4.10	2.54	2.26	0.42	0.99	0.42	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	9.24	6.77	3.32	3.32	1.35	1.85	0.99	0.00	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	3.76	3.22	1.61	3.22	0.81	0.27	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	14.74	10.90	2.85	2.73	3.59	2.97	1.12	0.00	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	18.00	10.24	2.21	3.05	2.91	2.21	1.38	0.00	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.37	5.69	2.64	1.83	1.83	1.22	0.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.06	7.07	2.74	3.88	1.60	2.74	0.91	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	12.71	7.85	1.37	2.99	1.12	2.12	0.25	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	15.52	10.93	2.84	3.72	2.19	1.31	1.75	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.52	7.39	2.07	2.95	1.77	0.89	0.59	0.00	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.49	7.79	2.23	1.91	0.79	2.86	0.32	0.00	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.62	7.37	3.57	2.68	0.22	2.01	0.67	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.08	7.66	2.82	2.42	2.42	2.82	0.81	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	8.31	7.46	2.21	2.37	2.04	2.21	1.70	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	19.42	9.58	3.64	2.04	1.68	1.86	1.42	0.09	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.79	16.23	6.76	3.43	4.99	3.43	3.33	0.21	2.29
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	13.83	13.32	4.10	2.90	3.07	4.10	1.37	0.17	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	10.18	7.64	2.88	2.99	3.21	3.54	1.88	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	16.89	9.23	3.83	2.50	1.91	2.33	1.58	0.08	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	14.91	10.62	3.27	2.25	1.63	2.25	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	11.14	7.43	2.06	2.27	2.89	3.92	0.41	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	9.11	7.84	2.77	2.77	2.54	5.30	0.23	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	8.67	5.50	4.84	4.00	2.00	3.17	1.17	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	8.60	8.60	2.42	3.31	3.09	3.31	1.10	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	7.38	5.41	4.06	2.71	2.58	3.69	0.49	0.12	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.83	6.65	4.05	2.76	2.76	1.62	0.49	0.32	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	7.06	6.74	2.89	2.57	3.53	4.49	1.92	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	5.78	5.21	3.70	2.08	2.08	2.84	0.66	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	6.80	7.28	1.90	3.80	1.74	2.06	1.11	0.00	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	7.60	4.87	1.82	3.04	0.91	2.13	0.30	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	5.96	5.12	2.51	1.88	2.51	2.09	1.05	0.10	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	8.56	5.27	2.42	1.54	1.54	1.76	1.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	5.33	3.65	1.40	1.68	2.24	2.24	0.28	0.00	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.41	6.20	2.04	1.76	2.13	2.87	0.46	0.09	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	4.81	8.02	2.14	1.34	1.87	1.34	0.80	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	6.12	4.90	2.30	1.68	0.92	1.38	0.61	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	6.74	3.89	1.30	1.17	1.81	1.94	0.00	0.13	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	8.13	4.88	4.34	2.71	2.44	2.44	0.54	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	8.48	5.71	2.58	1.84	0.92	1.29	0.37	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	5.70	6.58	3.73	0.88	1.32	1.32	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	6.94	7.93	5.95	4.96	3.97	1.98	0.99	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	6.99	6.86	2.90	1.19	1.45	2.37	0.79	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	8.88	6.25	2.62	0.61	1.41	1.61	0.20	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	30.75	16.77	14.49	5.59	6.61	6.35	3.05	0.51	2.29
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	3.58	2.79	3.18	3.98	0.40	0.80	0.40	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.39	4.47	4.78	5.08	0.92	1.08	0.92	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	5.73	2.45	2.45	3.07	0.20	2.05	0.20	0.61	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.07	3.44	1.25	3.44	0.94	0.63	0.94	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.04	1.41	0.85	2.54	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	2.77	2.77	3.69	2.77	0.00	0.46	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	2.47	4.95	4.95	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	15.47	7.74	1.93	1.16	0.77	0.77	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	11.23	0.00	3.21	0.00	1.60	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	6.96	5.22	1.74	0.00	0.00	5.22	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	10.09	4.23	0.98	1.63	0.33	1.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.88	6.18	1.65	0.41	0.00	0.82	0.82	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	16.66	10.00	3.33	0.00	6.66	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	9.51	5.59	1.12	3.36	0.00	0.56	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.48	4.25	0.65	2.29	0.33	1.31	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	22.65	9.23	6.71	2.52	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.18	3.50	0.64	1.91	0.64	1.59	0.64	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.81	2.72	2.38	2.38	0.34	0.00	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	12.53	2.09	2.09	0.00	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	8.02	4.01	3.44	0.57	0.00	2.29	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	7.99	3.85	1.78	2.07	0.30	0.00	0.30	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	6.78	1.69	1.69	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.01	8.28	1.24	2.49	0.83	0.00	0.83	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	12.66	8.74	1.84	3.22	0.23	1.38	0.23	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	21.07	0.00	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.53	5.00	1.15	2.31	0.38	0.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.82	5.22	1.96	2.61	0.98	0.00	0.98	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.71	5.35	0.67	2.01	2.01	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.56	10.79	1.93	3.47	1.16	2.31	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	18.14	7.19	4.11	3.42	1.03	2.74	0.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	9.94	4.97	2.48	2.48	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	22.18	8.97	3.77	2.83	0.47	3.30	2.36	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	12.07	8.45	1.21	1.21	0.60	3.02	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	13.23	9.66	4.07	4.07	1.53	1.53	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.55	10.77	3.59	3.19	0.00	1.99	1.20	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.85	8.39	3.95	2.96	1.48	2.47	1.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	10.62	3.54	3.54	1.18	3.54	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	8.17	5.83	1.17	2.92	2.92	1.75	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	11.85	10.97	2.19	3.51	1.76	2.19	2.63	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.97	8.48	5.93	7.63	1.70	1.70	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.13	8.95	1.79	0.60	1.19	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	11.16	5.82	3.88	1.94	0.00	1.46	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	2.28	0.00	2.28	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	2.49	1.66	0.83	2.49	0.83	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	2.25	0.00	0.00	1.12	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	5.07	3.49	0.95	2.54	0.63	0.95	0.63	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	0.42	0.84	1.25	1.25	0.42	0.00	0.84	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	4.99	2.32	0.93	1.04	0.46	0.35	0.46	0.00	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	7.09	4.22	1.01	0.84	0.00	0.00	0.17	0.17	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	5.69	3.41	0.91	0.91	0.68	0.46	0.91	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	5.14	4.15	0.77	0.98	0.33	0.22	0.33	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	4.94	4.94	1.07	0.00	0.21	0.43	0.64	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	4.31	5.60	1.29	1.51	0.22	0.00	0.43	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	5.73	2.74	1.00	0.25	0.25	0.00	0.12	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.92	2.74	0.86	0.86	0.00	0.51	0.17	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.81	3.20	0.32	0.32	0.00	0.00	0.32	0.00	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.72	6.72	2.80	1.12	1.12	1.12	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.92	5.63	1.30	1.30	0.43	1.30	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	5.29	0.00	0.00	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	16.58	6.00	5.29	3.53	0.71	0.35	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	2.91	5.09	0.73	0.00	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	9.62	6.82	1.40	1.40	0.17	0.35	0.70	0.00	0.00
Hepatocyte, donor1	11523-119I2	52.06	12.11	12.11	3.63	0.00	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	15.08	10.77	7.54	4.31	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	13.50	11.66	2.45	4.91	0.61	2.45	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	6.53	3.26	0.00	0.00	1.96	1.96	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	32.86	17.48	1.57	3.50	2.80	2.10	1.57	0.00	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	8.23	4.39	1.78	1.51	0.41	0.00	0.27	0.00	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	15.92	0.00	3.18	3.18	3.18	6.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	15.23	0.00	2.77	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	12.51	0.00	2.50	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87	0.00	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	13.71	0.00	0.00	9.14	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	21.12	3.25	1.62	1.62	1.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	8.34	1.67	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	0.00	7.26	0.00	3.63	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	7.94	0.00	3.97	1.32	1.32	6.62	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	9.98	0.00	3.33	0.00	3.33	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	26.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.82	10.08	0.00	0.63	0.63	1.89	0.63	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	10.83	0.00	0.00	3.09	1.55	0.00	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	15.50	0.00	1.94	1.94	1.94	1.29	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	8.05	3.22	1.61	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	11.95	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	11.41	8.15	0.81	3.26	0.00	0.00	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	7.98	12.17	1.26	2.52	0.84	1.26	1.68	0.00	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	43.12	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	16.88	0.80	1.61	2.41	0.80	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	12.00	0.00	1.85	0.00	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	5.66	9.91	0.47	0.94	0.94	0.94	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	4.53	0.00	0.00	0.00	1.81	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	8.61	0.00	1.08	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	8.89	0.00	3.81	0.00	0.00	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	8.93	5.74	0.00	1.28	1.91	0.64	1.28	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	5.47	0.00	0.00	0.00	3.65	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	6.43	9.28	0.00	3.57	0.71	0.00	2.14	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	3.32	3.32	0.00	0.00	0.00	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.10	7.72	0.62	1.54	0.93	0.62	0.93	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	8.78	7.02	1.76	1.76	1.76	1.76	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	15.72	0.00	3.14	3.14	3.14	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	15.30	1.39	2.09	1.39	2.09	1.39	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	17.70	0.00	4.43	4.43	6.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	22.69	9.73	9.73	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	20.93	17.44	2.62	0.87	0.87	0.00	0.87	0.00	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	6.75	15.75	0.00	9.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	13.94	0.00	0.00	0.00	3.48	0.00	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	20.27	21.34	2.13	1.07	0.00	1.07	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	16.63	9.70	0.00	4.16	0.00	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	19.95	2.85	0.00	8.55	2.85	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	23.93	0.00	2.76	1.84	1.84	1.84	0.00	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	15.13	3.03	0.00	9.08	0.00	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00	0.00	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	9.52	2.11	1.06	2.11	5.29	4.23	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	16.89	6.53	1.47	0.90	0.16	0.24	0.33	0.08	0.41
Keratinocyte - epidermal, donor2	11349-117G8	15.23	5.27	0.59	1.17	1.17	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.31	11.74	0.95	1.99	1.04	0.38	1.04	0.00	0.76
Keratinocyte - oral, donor1	11251-116E9	30.08	14.64	3.29	3.18	1.82	1.02	1.59	0.11	0.45
Keratocytes, donor1	11527-119I6	5.50	3.44	3.44	1.38	0.69	0.34	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	5.86	0.00	1.17	0.00	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	4.35	7.11	4.35	2.77	1.58	1.38	0.59	0.00	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	28.57	8.79	17.58	0.00	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	4.31	7.55	1.08	1.08	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	17.65	8.30	6.23	5.31	2.19	0.81	0.69	0.35	0.46
Lens Epithelial Cells, donor3	11690-122I7	7.16	4.34	1.82	2.83	1.21	0.50	0.61	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	25.26	6.52	2.85	2.96	0.71	0.24	0.12	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.02	7.81	2.23	1.40	0.28	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	33.53	8.34	3.62	2.36	0.63	0.31	0.47	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	19.36	4.84	0.54	0.00	0.54	0.54	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.53	5.04	1.26	1.26	0.32	0.63	0.32	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.34	5.93	2.59	0.97	0.22	0.22	0.32	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	10.67	3.69	0.41	0.41	0.41	0.41	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.73	4.05	1.26	0.76	0.51	0.51	0.25	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.96	7.04	2.53	1.97	0.14	0.56	0.28	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	34.02	9.89	3.56	2.37	0.79	1.19	0.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.33	8.34	2.33	1.94	0.58	0.58	0.39	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.63	3.33	0.93	1.48	0.37	0.00	0.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.10	8.36	1.39	3.14	0.35	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	36.26	7.39	2.86	2.39	0.24	0.95	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	18.54	6.59	1.79	0.69	0.14	0.41	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	33.57	9.24	2.46	1.85	0.62	0.62	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.19	4.99	1.25	0.00	0.00	0.31	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.13	6.77	4.03	1.83	0.00	0.55	0.55	0.00	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	32.58	6.25	1.97	1.32	0.99	0.99	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.36	7.03	2.05	0.59	0.29	0.59	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.41	5.23	1.74	0.75	0.25	0.50	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	39.28	8.24	3.88	0.97	0.48	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	44.97	9.96	2.96	1.35	0.27	0.81	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	17.56	5.45	2.57	0.76	0.91	0.45	0.15	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	20.22	5.70	1.56	0.52	0.00	0.52	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	56.33	10.47	2.51	0.84	0.63	1.05	0.63	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	17.29	5.26	1.95	0.90	0.00	0.90	0.30	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.95	5.50	1.38	2.06	0.00	0.69	1.38	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	40.08	6.77	2.63	1.13	0.56	0.00	0.38	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	16.43	4.03	1.59	0.95	0.32	0.11	0.42	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	30.53	7.75	1.94	2.42	0.48	0.00	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	32.09	5.62	1.32	1.32	0.33	0.66	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	15.36	4.46	2.23	1.36	0.50	0.12	0.50	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	26.28	7.40	4.81	1.48	0.00	0.74	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.06	8.15	3.95	0.99	0.49	0.74	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.64	5.91	0.69	0.82	0.00	0.14	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	33.77	9.33	3.54	1.93	1.29	0.96	0.00	0.00	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.95	9.74	2.74	3.96	0.30	0.30	1.22	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	27.71	9.24	1.68	1.12	0.28	0.42	1.12	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.60	4.98	2.84	1.42	0.00	1.42	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	27.63	4.36	1.45	0.97	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	12.60	4.20	1.40	0.93	0.47	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.62	6.45	1.07	0.72	0.36	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.99	9.80	1.63	1.96	0.00	0.00	0.33	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	12.24	4.94	0.94	0.71	0.00	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	27.97	6.44	3.34	2.60	1.11	0.74	0.87	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	23.05	5.38	3.33	1.02	0.26	0.51	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	5.67	1.19	1.49	0.30	0.30	0.30	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	15.86	0.00	2.27	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.88	11.51	1.53	0.77	0.00	0.00	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	14.10	11.13	2.23	1.48	0.74	2.23	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	13.96	1.27	1.27	0.00	0.00	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.07	6.33	2.81	2.81	1.41	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	10.27	0.00	0.00	0.00	0.00	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	6.70	0.52	0.00	0.00	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	8.33	0.00	0.00	0.00	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	14.70	13.57	1.58	1.13	0.90	0.45	0.90	0.23	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.19	9.60	1.45	0.58	0.00	1.16	0.87	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.21	9.90	1.80	2.25	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	31.57	16.53	2.03	2.71	0.41	0.54	1.22	0.27	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	13.87	10.27	3.08	3.08	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	14.47	11.29	0.35	2.12	0.71	0.35	0.35	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	8.66	2.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.81	13.75	3.57	1.53	0.00	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	13.07	8.27	1.07	2.93	1.60	0.00	0.53	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	17.76	10.77	1.51	2.08	0.38	0.38	0.57	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	12.27	3.68	1.84	0.61	0.00	1.84	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	20.39	13.05	1.63	3.26	1.63	0.82	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	20.20	12.08	1.87	2.50	0.62	0.83	0.21	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	18.22	11.21	1.40	1.12	0.00	0.28	0.00	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	13.39	1.03	6.18	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.52	9.58	2.03	2.61	0.87	0.87	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	8.67	1.49	0.90	0.30	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	8.30	1.66	3.32	1.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	12.02	3.18	2.83	0.35	0.35	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.86	10.69	3.32	1.48	0.00	0.37	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	8.06	6.91	0.00	1.15	0.00	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.51	13.82	1.54	4.61	0.38	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.62	10.76	1.70	2.26	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	8.20	1.64	4.10	0.00	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	17.62	12.20	1.81	3.62	0.90	0.45	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.21	6.46	0.72	0.00	0.00	0.72	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	12.70	4.48	2.24	0.00	2.24	1.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	16.72	9.66	0.74	2.60	0.00	0.00	1.49	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	7.32	2.15	0.43	0.43	0.43	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	13.70	10.28	4.28	2.57	0.86	1.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.32	9.33	3.33	2.33	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	12.67	1.81	1.81	0.00	1.81	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	9.95	3.55	3.55	0.00	0.00	0.00	0.00	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.28	9.62	2.75	3.09	1.03	1.03	0.69	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	18.25	10.73	3.76	0.54	0.54	0.00	0.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	10.77	0.67	3.37	0.67	0.67	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	23.71	9.26	1.85	3.70	0.74	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	12.79	0.00	4.65	0.00	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	12.69	3.17	3.17	1.06	2.12	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.41	12.40	2.00	2.80	0.00	0.80	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	9.45	0.73	0.00	0.73	0.73	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	20.70	12.26	3.07	0.77	0.00	0.00	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	12.83	0.99	2.47	0.99	0.00	1.48	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	13.17	3.76	0.94	0.00	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	13.07	0.50	5.03	0.00	0.50	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	13.52	1.80	1.80	0.00	0.45	0.45	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	8.61	3.44	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	22.71	16.48	3.56	2.67	0.45	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.03	14.86	2.35	2.74	0.39	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	11.88	0.66	2.64	1.32	1.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.20	12.97	2.59	3.11	1.04	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	24.94	14.00	0.88	3.94	0.44	0.00	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	21.80	16.21	0.56	1.12	0.00	0.00	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	25.17	17.22	1.77	2.21	0.00	1.32	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	25.46	15.43	3.09	2.31	1.16	0.39	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	14.18	12.15	1.01	0.51	0.00	1.01	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	16.34	9.61	1.92	0.96	0.48	1.44	1.44	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	20.27	14.31	2.39	1.59	0.40	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.01	11.54	3.04	1.82	0.61	0.61	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	7.61	0.69	2.08	0.00	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.76	8.74	2.28	2.66	0.76	0.38	1.52	0.76	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	20.14	14.46	2.07	2.07	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.05	13.91	2.42	3.63	0.60	0.00	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	26.30	9.82	1.58	2.54	0.00	0.95	0.32	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	16.53	5.33	3.20	2.13	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	17.24	1.15	1.72	1.72	0.57	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	24.68	10.80	2.06	2.57	0.00	0.51	0.00	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	12.73	4.24	2.12	0.00	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	10.21	2.84	2.27	0.57	0.00	0.00	0.00	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	19.14	11.23	1.25	4.16	0.42	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.01	14.88	0.78	0.00	0.00	0.00	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.02	12.94	0.00	2.51	0.84	0.84	0.84	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.16	8.36	3.72	3.25	0.93	1.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.73	8.03	3.35	1.34	0.00	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.97	12.30	1.07	3.21	1.07	1.60	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	25.86	10.51	1.21	3.64	0.00	0.00	0.40	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	10.10	1.84	2.75	0.00	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	12.45	23.12	0.89	5.33	0.89	1.78	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	31.34	13.11	2.85	6.84	0.00	1.14	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	24.54	13.80	1.53	0.77	0.00	0.00	0.00	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	14.77	1.64	4.38	0.00	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	29.40	10.25	4.45	2.67	0.00	0.45	1.78	0.45	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	38.73	16.90	2.60	4.16	1.04	0.52	0.78	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	17.24	0.66	5.97	0.66	0.00	1.33	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	22.86	31.18	2.08	0.00	0.00	2.08	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	11.62	9.80	1.60	1.37	2.96	1.14	1.82	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	0.73	1.47	0.37	0.55	0.55	0.18	0.18	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	6.55	3.54	1.05	1.57	1.05	0.66	0.79	0.13	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.97	1.06	2.66	0.00	0.00	1.06	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	9.98	6.34	1.74	0.48	0.16	0.16	0.48	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	11.12	6.67	0.69	1.67	0.00	0.00	0.28	0.00	0.28
Mammary Epithelial Cell, donor1	11273-116H4	27.90	14.35	3.39	2.09	0.80	0.30	1.00	0.10	0.20
Mammary Epithelial Cell, donor2	11350-117G9	24.61	12.45	2.32	2.32	0.58	0.58	0.87	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	7.98	2.99	1.00	0.75	0.25	0.00	1.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	54.23	26.44	3.39	3.39	2.03	0.68	0.68	0.00	0.68
Mast cell, donor1	11563-120D6	3.46	4.54	0.87	0.87	2.27	1.51	0.65	0.00	0.32
Mast cell, donor2	11565-120D8	11.89	15.75	3.57	2.08	3.27	1.19	1.78	0.30	0.59
Mast cell, donor3	11566-120D9	18.69	27.24	0.90	5.85	7.20	2.25	2.48	0.23	2.48
Mast cell, donor4	11567-120E1	8.33	13.47	1.77	3.01	5.32	2.13	1.42	0.00	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	2.44	2.33	0.44	0.33	1.11	0.78	0.44	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	2.92	5.84	2.33	0.00	0.58	0.00	0.58	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	1.38	3.21	0.46	0.46	1.38	0.69	0.57	0.00	0.80
Mast cell, expanded, donor8	11941-126A6	12.39	14.23	2.01	0.67	0.84	2.18	2.68	0.17	0.84
Melanocyte - dark, donor1	11502-119F8	23.68	8.06	4.28	3.18	0.60	0.70	0.60	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	11.42	9.34	2.77	1.38	0.35	0.00	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	4.20	2.83	1.88	2.68	1.59	0.94	0.72	0.00	0.72
Melanocyte - light, donor1	11274-116H5	4.47	2.82	2.12	0.71	0.71	0.94	0.71	0.47	0.24
Melanocyte - light, donor2	11351-117H1	3.41	1.36	0.68	2.05	0.68	0.68	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	8.67	1.73	2.60	0.00	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	3.54	3.23	2.19	0.83	1.77	0.62	0.52	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	2.96	3.23	0.54	0.27	1.08	1.08	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	4.82	5.09	2.68	1.87	1.61	2.14	0.80	0.00	0.54
Meningeal Cells, donor1	11493-119E8	7.07	9.30	1.61	0.99	1.86	0.74	1.49	0.12	0.12
Meningeal Cells, donor2	11573-120E7	1.76	5.72	4.84	0.00	1.76	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	6.93	5.71	1.22	0.65	0.90	0.57	0.49	0.00	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	5.42	3.99	0.86	0.86	0.00	0.29	1.14	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	5.53	2.52	2.52	0.81	0.60	0.30	0.10	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00	0.00	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2.15	1.44	0.72	2.15	0.72	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.26	3.81	1.27	1.06	1.27	0.85	0.42	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	3.02	3.52	1.51	0.50	0.00	0.00	0.50	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.59	2.64	0.66	0.22	0.44	0.22	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	1.46	2.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.52	3.27	0.20	0.82	0.61	0.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.91	4.29	1.80	2.08	0.55	0.55	0.83	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	1.49	2.97	0.37	0.37	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.68	5.26	5.66	2.50	0.53	0.66	0.13	0.13	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	3.26	2.08	1.19	1.78	0.89	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	4.67	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	1.28	1.28	0.00	2.56	1.28	0.00	0.64	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	5.67	4.61	0.71	0.71	1.06	0.71	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	5.94	5.32	1.25	0.00	1.25	0.94	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	3.63	2.90	0.00	0.73	0.00	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	19.89	6.36	4.77	2.12	0.80	0.53	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	9.01	3.50	0.00	3.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	20.81	4.62	3.61	1.81	0.43	0.14	0.14	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	6.75	1.35	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.36	11.08	2.71	2.71	0.49	0.49	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	3.83	7.36	0.29	0.00	0.59	0.88	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00	3.46	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	6.82	1.24	2.17	1.24	0.00	0.00	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.32	1.24	1.24	0.21	1.04	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	2.32	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	10.01	9.26	2.25	0.75	0.75	0.00	1.00	0.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.98	2.79	0.93	0.47	0.47	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.91	5.69	1.83	1.83	1.42	1.02	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	2.77	3.56	0.79	0.40	0.40	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	2.65	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.04	2.66	0.38	0.38	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	3.95	1.32	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	3.18	3.18	0.42	1.27	0.85	0.85	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	1.84	0.00	0.00	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	4.17	2.38	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	5.03	0.00	0.00	0.00	0.00	1.68	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	3.01	1.25	0.00	0.25	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	4.28	2.38	0.24	0.24	0.48	0.48	0.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	2.21	0.00	0.55	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	2.07	2.76	0.00	0.46	0.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.73	2.31	0.63	0.63	0.42	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.28	5.30	0.41	0.61	0.41	0.61	0.00	0.00	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	3.65	3.86	1.07	1.07	0.64	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	5.56	3.11	0.00	0.67	0.00	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.26	5.91	0.44	0.00	0.00	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.10	3.04	0.00	0.51	0.00	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	6.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.16	4.08	0.82	0.82	0.82	0.54	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.53	2.65	0.59	0.88	0.29	0.00	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	7.63	1.09	2.18	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	5.77	0.48	1.44	0.00	1.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	6.80	1.20	0.80	1.20	0.40	0.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	9.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	12.51	6.01	2.00	0.00	1.00	0.50	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	36.69	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	22.33	6.57	0.44	2.19	0.44	0.44	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	5.52	4.41	0.00	1.10	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	44.19	6.40	0.64	4.48	1.92	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	22.56	12.15	2.23	1.49	0.50	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	8.35	5.57	0.70	1.39	0.00	1.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	13.26	2.21	6.63	0.00	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.46	8.89	2.39	2.05	1.03	0.34	1.03	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	6.56	0.88	0.88	0.44	0.00	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	24.50	7.81	1.42	2.13	0.00	1.42	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.88	11.50	1.40	1.96	1.12	1.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	6.23	2.91	0.42	0.83	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.32	5.83	1.17	1.17	2.33	2.91	0.00	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.89	13.27	1.81	2.41	0.90	1.51	2.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	6.26	5.84	1.25	1.25	0.83	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	21.24	12.01	1.85	0.92	3.69	1.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	6.26	4.55	0.57	0.00	0.00	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.83	5.53	1.11	2.90	1.11	1.38	0.41	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.88	13.48	0.52	2.07	1.55	1.04	0.00	0.00	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.01	3.86	0.00	1.72	0.86	0.86	0.43	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.33	7.62	1.27	2.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.81	7.47	2.40	0.80	1.60	0.80	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	5.99	5.09	1.20	0.60	1.20	0.30	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.44	4.94	1.27	1.27	1.27	0.85	0.42	0.00	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.83	9.24	1.59	1.59	0.96	0.32	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	6.86	4.64	0.44	1.55	0.88	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	14.03	5.69	1.52	1.52	1.52	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.22	7.39	0.28	1.42	2.27	0.85	0.28	0.00	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	7.37	3.69	1.23	0.49	1.23	0.98	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	3.26	0.00	0.00	0.65	0.65	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.70	9.41	0.59	1.18	1.18	0.29	0.59	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	3.75	4.32	1.15	1.44	0.29	0.58	0.58	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	13.60	13.60	0.41	2.47	0.41	0.00	0.82	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	7.44	6.25	0.60	1.79	1.79	1.79	0.89	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	5.35	0.00	0.00	0.00	0.00	3.56	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	10.51	6.24	2.63	4.60	0.66	0.33	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	1.05	4.21	0.00	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	8.30	6.72	0.99	2.17	0.79	0.00	1.38	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	6.52	0.00	3.73	1.86	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.66	11.64	3.00	3.00	1.13	0.75	0.00	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.20	3.73	0.80	0.53	1.33	1.07	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.54	4.86	0.23	0.45	1.36	0.45	0.23	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	10.31	5.89	1.47	1.47	2.21	0.00	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.82	5.50	2.20	2.20	2.56	0.00	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	7.78	4.67	0.00	0.00	1.56	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	4.81	5.34	0.00	0.00	0.53	1.07	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	15.15	3.03	2.02	1.01	2.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	2.53	0.84	0.42	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	1.27	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	1.62	0.00	0.00	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	1.51	0.00	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	5.71	5.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	19.57	6.52	0.00	0.00	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	9.50	0.00	0.00	4.75	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	9.69	4.74	2.15	0.65	0.22	0.22	0.22	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.88	6.79	7.32	2.61	0.52	0.00	1.57	0.00	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	0.67	2.67	4.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.51	5.84	5.43	2.50	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	5.89	4.75	0.95	0.95	0.38	0.38	1.33	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	14.36	9.58	3.19	7.98	1.60	0.00	1.60	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	4.08	2.72	2.04	1.36	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	7.35	0.00	0.00	0.00	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.72	4.60	5.86	3.35	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	4.65	2.56	1.16	0.46	0.46	0.23	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.08	10.27	11.62	3.78	0.81	0.00	0.54	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	14.72	8.20	6.94	3.78	0.42	0.21	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	9.43	2.98	1.99	1.49	0.00	0.99	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	5.95	4.06	2.71	1.08	0.54	0.54	0.00	0.54	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.35	4.99	5.67	1.59	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	10.94	5.88	9.80	3.27	0.33	0.16	0.49	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.84	5.29	5.65	2.19	0.91	0.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	4.24	9.02	3.71	0.00	0.53	0.53	2.12	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	15.61	6.00	10.21	3.60	0.00	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	7.22	4.59	0.98	0.66	0.66	0.66	0.33	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.27	4.23	8.29	1.79	0.16	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.88	6.88	10.94	4.06	0.71	1.41	0.18	0.71	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	4.92	9.14	1.41	0.00	1.41	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.25	8.73	9.19	3.68	0.00	0.00	0.00	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	10.60	3.21	9.64	2.25	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	13.11	5.52	4.48	2.41	0.34	0.00	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	7.59	15.17	5.06	0.00	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	8.69	6.02	10.25	2.67	0.89	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	5.08	7.20	5.08	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.00	5.70	4.03	3.09	0.24	0.24	0.71	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	8.58	6.87	12.02	1.72	0.86	0.43	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	6.66	12.66	4.00	0.00	0.00	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	8.12	9.47	4.51	1.35	0.90	0.45	0.00	0.90	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	3.17	3.97	2.38	0.00	0.00	0.40	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	1.86	5.57	3.71	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	5.68	3.03	2.27	1.51	0.00	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.17	5.54	4.24	3.58	0.00	0.00	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.46	5.23	14.38	2.18	0.00	0.87	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	7.69	7.24	6.33	2.26	0.45	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	4.41	8.82	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	5.32	11.30	3.32	0.00	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	6.45	14.39	4.96	0.00	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.87	3.06	9.19	3.45	0.00	1.53	0.00	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	5.14	7.56	3.02	0.00	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	5.30	4.64	3.32	1.11	0.00	0.44	0.22	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	5.42	4.07	0.68	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	5.11	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	7.32	8.54	2.44	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.04	4.09	6.61	3.15	0.00	0.31	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	10.59	3.93	13.62	5.15	0.00	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	1.58	9.49	3.16	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	5.67	2.27	3.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	4.10	3.98	1.24	0.50	0.62	0.00	0.12	0.00	0.12
Myoblast, donor2	11322-117D8	5.75	2.69	2.49	1.15	0.38	0.58	0.00	0.00	0.38
Myoblast, donor3	11398-118D3	6.39	4.37	1.35	0.34	0.50	0.34	0.34	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	194.04	178.36	1.54	3.69	10.15	3.69	5.84	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	162.54	199.93	2.71	4.22	6.03	5.43	4.22	0.30	0.90
Natural Killer Cells, donor3	11387-118C1	137.49	161.42	3.13	5.89	7.55	5.71	4.60	0.18	2.58
Neural stem cells, donor1	11275-116H6	26.49	19.24	16.33	4.72	1.81	1.81	1.09	0.36	1.45
Neural stem cells, donor2	11352-117H2	30.81	23.11	32.74	11.55	1.93	9.63	0.00	0.00	0.00
Neurons, donor1	11494-119E9	11.38	11.38	12.52	2.28	1.14	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	8.81	7.05	15.19	4.40	3.08	5.28	0.44	0.66	0.00
Neurons, donor3	11655-122E8	10.69	4.11	13.15	2.47	0.82	4.11	0.00	1.64	0.00
Neutrophils, donor1	11233-116C9	224.58	262.63	8.35	5.57	31.55	23.20	6.50	1.86	5.57
Neutrophils, donor2	11314-117C9	130.45	278.29	14.49	5.80	26.09	11.60	8.70	0.00	11.60
Neutrophils, donor3	11390-118C4	230.29	375.06	4.89	19.55	47.03	32.99	19.55	0.00	13.44
Nucleus Pulposus Cell, donor1	11252-116F1	11.75	6.89	5.82	3.80	1.07	1.90	0.83	0.24	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	2.93	3.91	2.93	0.65	0.65	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	1.80	6.02	2.41	1.20	1.00	0.60	0.20	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	5.78	4.54	3.58	1.24	0.69	0.00	0.41	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	7.09	6.80	2.61	2.17	0.14	0.14	0.58	0.00	0.29
Olfactory epithelial cells, donor3	11935-125I9	7.38	4.65	2.84	1.25	0.45	0.00	0.57	0.00	0.34
Olfactory epithelial cells, donor4	11936-126A1	5.65	4.38	4.09	1.17	0.88	0.10	0.58	0.00	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	14.44	6.62	1.20	2.41	1.81	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	5.10	4.04	4.25	1.06	0.21	0.21	0.64	0.43	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	0.00	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	9.93	2.48	4.34	1.24	0.62	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	5.47	3.52	0.78	0.20	0.20	0.20	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	6.32	6.32	3.51	1.40	0.00	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	5.33	4.98	1.60	1.07	0.53	0.18	0.18	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	8.09	6.82	1.94	1.68	1.01	0.25	1.01	0.00	0.17
Pericytes, donor1	11491-119E6	1.34	1.56	0.89	0.45	1.00	0.22	0.56	0.00	0.00
Pericytes, donor2	11571-120E5	1.36	4.53	1.58	0.68	0.68	0.45	0.68	0.23	0.00
Pericytes, donor3	11652-122E5	4.68	1.83	1.02	0.61	0.20	0.00	0.20	0.00	0.00
Perineurial Cells, donor1	11499-119F5	5.99	5.31	2.49	2.03	0.79	0.34	1.02	0.00	0.11
Perineurial Cells, donor2	11579-120F4	25.40	9.66	5.24	4.14	1.29	0.46	1.01	0.00	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	169.25	183.91	1.59	7.33	12.11	5.74	6.69	0.00	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	86.19	88.64	2.94	5.39	4.90	3.43	3.43	0.49	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	123.59	136.66	4.40	7.51	7.76	5.56	6.47	0.26	2.59
Placental Epithelial Cells, donor1	11278-116H9	24.16	10.52	1.43	0.96	0.00	0.72	0.96	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	1.11	8.87	1.11	0.00	0.00	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	8.83	8.44	0.59	0.98	0.39	0.59	0.98	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	7.91	3.48	1.90	0.63	0.00	0.00	0.63	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	13.13	3.19	4.31	1.31	0.00	0.00	0.75	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.57	4.44	9.40	3.92	0.26	0.26	0.65	0.39	0.00
Preadipocyte - breast, donor2	11328-117E5	8.56	4.95	4.95	1.80	0.23	0.45	0.68	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	8.95	4.80	7.99	2.24	0.32	0.11	0.32	0.75	0.21
Preadipocyte - omental, donor2	11329-117E6	11.78	4.36	6.55	2.62	0.44	0.00	0.44	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	13.32	3.58	5.87	1.86	0.86	0.57	0.72	0.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	0.98	2.95	1.97	0.00	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.07	1.23	0.31	0.00	0.00	0.31	1.23	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	7.44	8.32	1.42	1.24	1.24	0.53	0.89	0.18	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	2.72	4.09	0.51	0.85	0.34	0.00	0.68	0.00	0.34
Preadipocyte - visceral, donor1	11280-116I2	9.41	8.20	1.96	1.40	1.02	0.56	0.75	0.09	0.56
Preadipocyte - visceral, donor2	11357-117H7	11.96	8.28	0.92	2.30	0.92	0.00	0.92	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	1.99	6.06	1.15	1.04	0.94	0.31	0.21	0.10	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	31.53	10.26	2.56	3.17	2.26	1.21	1.36	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	9.48	5.42	1.90	1.08	0.27	0.27	0.68	0.00	0.27
Prostate Epithelial Cells, donor3	11404-118D9	46.66	17.39	4.84	2.88	1.47	0.86	0.55	0.06	0.67
Prostate Stromal Cells, donor1	11254-116F3	6.38	3.19	1.37	1.03	0.34	0.00	0.46	0.00	0.11
Prostate Stromal Cells, donor2	11332-117E9	6.99	6.63	2.33	0.72	0.54	0.54	0.72	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	5.63	3.13	4.48	1.88	0.83	0.21	0.42	0.21	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.95	8.76	1.46	1.46	2.19	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	13.72	8.25	1.32	1.52	1.32	0.69	0.83	0.07	0.42
Renal Epithelial Cells, donor1	11517-119H5	11.16	7.61	0.51	0.51	0.51	0.00	1.01	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	9.25	7.11	1.42	0.71	0.00	0.00	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	20.43	9.85	1.06	1.06	1.69	0.64	1.06	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	9.53	10.89	0.68	1.36	0.68	0.00	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.76	5.39	1.35	2.43	0.54	0.00	0.27	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	14.65	9.77	2.44	2.66	0.00	0.44	0.44	0.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	14.64	5.32	2.00	1.33	1.33	0.00	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.92	4.18	1.76	0.66	0.88	0.66	0.88	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	8.15	6.90	0.63	0.63	0.63	0.63	0.63	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	3.88	2.77	0.55	0.55	1.11	0.00	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	15.30	9.66	0.27	1.34	1.34	0.54	1.34	0.00	1.07
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	4.22	1.69	0.42	0.00	1.69	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.57	6.36	0.00	0.96	1.93	0.19	1.74	0.00	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.45	6.48	3.89	2.59	1.56	1.04	0.00	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	3.41	3.41	2.84	0.00	0.00	0.85	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	3.09	1.03	0.00	0.00	0.00	0.00	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	3.01	7.78	4.27	1.25	1.00	1.00	0.50	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	48.11	19.38	13.23	7.35	4.28	2.14	1.87	0.40	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	18.76	8.04	1.79	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.26	14.86	7.71	0.55	0.55	0.55	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	33.64	22.62	6.38	6.96	0.00	1.16	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	9.62	9.49	3.12	3.25	1.56	0.78	1.43	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.61	9.63	3.87	2.58	1.29	0.89	1.59	0.10	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	14.95	8.25	3.79	3.57	1.12	0.89	1.12	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.93	7.07	3.10	4.09	1.49	1.12	1.74	0.00	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	10.02	9.44	3.85	3.38	1.17	1.52	1.40	0.12	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.72	8.32	2.54	3.00	1.16	0.69	0.23	0.00	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	5.20	11.09	2.05	4.38	1.51	1.51	1.78	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	8.62	9.08	3.48	3.18	1.36	1.21	0.61	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	11.65	9.14	3.58	2.33	1.97	0.90	0.90	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	6.17	8.46	3.73	4.30	1.86	2.01	2.30	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.16	7.30	2.90	2.58	0.97	1.07	1.61	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	9.51	7.97	4.87	4.43	0.89	0.66	1.99	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.35	12.24	3.44	7.07	1.34	1.91	1.53	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	9.69	8.01	3.82	2.70	1.58	0.84	0.65	0.28	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.10	11.27	4.32	2.25	0.56	1.32	2.07	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.43	14.73	5.18	6.37	2.12	0.93	0.66	0.93	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.58	11.39	3.80	5.06	2.04	1.65	1.17	0.19	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	11.46	10.69	3.06	3.63	1.53	1.15	1.91	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	9.08	12.92	3.31	4.91	1.82	1.50	1.92	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	8.41	4.77	4.20	1.40	1.40	0.84	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.36	9.23	3.08	3.42	1.03	2.91	1.03	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.93	11.67	3.28	4.92	1.64	1.09	0.73	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.53	10.30	3.92	4.41	1.72	0.74	1.10	0.25	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.91	7.92	4.43	4.16	0.94	2.28	1.34	0.27	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.84	10.85	2.83	3.07	1.42	1.42	1.18	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.51	11.51	2.58	2.78	1.98	1.98	1.59	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.16	12.86	4.68	3.27	1.40	1.40	1.40	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.98	10.78	1.66	3.73	1.45	1.45	1.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	8.63	11.28	3.98	4.65	1.99	1.11	1.33	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.58	7.94	4.60	3.34	1.46	0.42	1.67	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	6.86	7.67	3.50	4.85	2.02	0.81	1.08	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.92	7.83	3.92	3.41	0.85	1.02	1.02	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	9.45	11.18	5.40	3.66	2.31	1.74	1.35	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	4.13	10.83	1.89	2.41	1.03	2.58	1.03	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.88	7.41	2.74	3.02	1.37	1.65	1.23	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.15	8.37	3.61	1.64	0.66	1.15	0.82	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	5.79	8.86	2.90	5.62	1.53	2.05	2.05	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	11.84	7.99	2.22	3.11	1.92	0.89	1.18	0.15	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.86	11.46	4.53	4.00	0.53	1.87	1.33	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	8.71	13.96	6.50	10.09	2.63	1.80	1.94	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.48	8.10	3.33	3.10	1.67	2.38	1.67	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	14.51	12.70	7.66	5.24	2.02	2.42	1.41	0.20	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	8.29	11.02	4.90	4.43	1.51	1.79	2.17	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	18.17	14.32	8.38	4.89	0.70	1.75	2.45	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	18.13	13.60	10.28	6.04	1.81	2.42	0.91	0.60	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.22	15.05	4.41	5.26	1.22	0.73	1.47	0.37	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	39.30	20.96	16.16	5.68	1.60	3.20	5.09	0.44	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.25	14.60	4.87	6.08	0.61	1.22	0.61	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	5.73	12.66	3.62	3.01	3.01	0.90	3.32	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.04	14.02	8.82	5.88	1.13	1.13	2.71	0.68	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	30.55	17.97	13.78	8.09	1.20	2.40	1.50	0.30	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	10.15	13.70	5.08	5.31	0.59	1.42	1.42	0.71	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	17.72	12.59	9.39	6.40	1.28	1.71	2.13	0.21	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.64	19.83	7.21	7.81	2.40	0.00	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	3.39	4.14	0.75	0.56	0.94	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	0.00	0.00	0.00	3.40	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	5.26	4.60	1.53	1.75	0.66	0.88	0.22	0.00	0.44
Sebocyte, donor1	11220-116B5	39.44	18.62	0.55	1.64	1.64	1.10	0.55	0.00	0.55
Sebocyte, donor2	11301-117B5	19.76	7.81	3.22	2.76	0.46	0.00	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	11.34	5.77	2.68	0.62	1.03	0.82	0.82	0.00	0.00
Sertoli Cells, donor1	11255-116F4	23.19	6.63	4.97	1.66	0.00	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	8.47	11.30	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	13.55	8.89	2.55	1.32	1.06	0.97	0.88	0.18	0.70
Skeletal Muscle Cells, donor2	11358-117H8	5.78	0.72	4.34	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.02	4.18	0.84	2.51	0.84	0.00	0.84	0.00	1.67
Skeletal Muscle Cells, donor4	11451-119A2	3.30	4.08	1.57	1.10	0.79	0.31	0.63	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	4.31	7.28	3.12	1.78	0.45	0.59	0.74	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	3.08	6.31	0.77	1.54	0.62	0.46	0.31	0.00	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	10.58	8.06	2.90	1.64	0.50	0.00	0.38	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.13	7.42	2.71	2.71	0.29	0.29	0.29	0.14	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	10.62	6.25	2.28	1.98	0.60	0.50	1.09	0.30	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	11.71	7.75	2.70	0.84	0.93	0.42	0.84	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	9.41	6.51	0.72	0.72	0.72	0.00	2.17	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	4.82	2.34	1.51	1.10	0.55	0.00	0.28	0.00	0.14
Skin - palm, donor1	10286-104F7	110.13	26.86	26.86	16.12	0.00	0.00	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.08	5.62	0.86	1.01	0.86	0.29	0.00	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	49.07	31.90	2.45	1.64	0.82	0.82	0.00	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	9.61	4.41	1.17	0.91	0.13	0.00	0.65	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	25.86	10.29	1.25	1.53	0.56	0.00	0.14	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	21.10	12.24	2.25	3.24	0.98	0.98	0.56	0.00	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	61.32	21.57	1.90	5.50	1.48	0.21	1.06	0.00	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	46.47	17.76	4.42	4.27	1.12	0.97	0.90	0.15	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.63	6.17	2.16	1.54	0.62	0.31	0.93	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.67	5.34	2.22	1.78	1.56	0.00	0.44	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	14.11	3.53	1.76	0.00	1.76	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	34.03	7.73	3.54	3.31	0.22	0.00	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	6.69	1.58	0.79	1.18	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	14.68	3.09	0.00	2.32	0.00	0.00	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	5.00	4.00	7.01	1.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.31	3.59	1.46	0.27	0.00	0.27	0.27	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.98	7.54	1.77	0.44	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.81	5.63	1.15	1.28	0.38	0.00	0.00	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.56	2.60	0.33	1.30	1.30	0.65	0.33	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	4.13	3.25	2.95	2.36	0.59	0.89	0.30	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.68	3.27	2.42	1.85	0.28	0.00	0.57	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	1.79	1.79	0.98	0.33	0.16	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.00	5.18	6.39	1.83	0.61	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.84	4.29	2.78	1.01	0.76	0.76	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	7.15	0.95	1.91	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	6.93	3.54	0.44	1.03	0.74	0.74	0.15	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	5.17	6.03	1.72	1.29	0.86	0.43	0.65	0.00	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	8.71	4.51	2.83	1.57	1.05	1.15	0.63	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	6.50	2.63	0.46	0.46	0.15	0.00	0.00	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	1.08	1.08	0.00	0.00	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.68	4.18	1.20	0.30	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.41	3.07	1.37	1.37	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.23	7.15	4.16	2.59	0.16	0.47	1.10	0.08	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.98	7.15	2.11	0.60	0.91	0.30	0.50	0.20	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.31	9.33	4.10	2.50	0.46	1.14	0.23	0.00	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	3.62	0.60	1.21	0.00	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	11.39	9.27	1.59	1.85	1.32	1.06	0.53	0.26	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	2.26	3.99	0.80	0.80	0.67	0.13	0.67	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	8.01	4.76	2.38	1.25	0.25	0.50	0.13	0.00	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.60	4.06	4.31	1.01	0.51	1.01	0.51	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	17.49	5.43	3.47	1.66	1.06	0.30	0.45	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	8.25	2.25	3.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	87.87	27.14	31.01	33.60	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	9.30	8.37	3.72	0.93	0.47	0.47	0.47	0.47	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	12.62	3.53	3.03	2.52	0.00	0.00	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.28	5.33	3.76	3.13	0.63	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.65	2.65	1.18	0.59	0.59	0.59	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.16	7.58	1.58	2.08	1.08	0.17	1.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	6.07	9.34	4.67	0.00	0.93	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.17	1.58	0.43	0.29	0.29	0.14	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	12.49	7.14	1.27	1.53	0.76	0.25	0.25	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	4.14	2.07	1.50	0.94	0.56	0.00	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	6.15	5.59	0.84	2.38	0.98	0.56	0.56	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.04	5.11	1.59	2.18	0.75	0.34	0.84	0.00	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	3.33	1.43	1.43	0.00	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.65	4.16	0.00	0.24	0.24	0.00	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	5.74	6.19	2.21	1.99	0.66	0.44	0.22	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.44	1.46	1.46	1.17	0.29	0.29	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	3.30	5.25	2.92	1.17	0.39	0.19	0.58	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	5.29	3.70	2.38	0.26	0.26	0.26	0.00	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	1.49	1.86	1.49	0.37	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	5.39	3.59	2.87	0.36	0.00	0.72	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	7.38	2.27	0.57	0.28	0.00	0.28	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	7.09	2.36	1.58	0.79	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.89	3.56	3.56	1.27	0.00	0.25	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	7.59	3.19	4.79	1.20	0.40	0.40	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	4.18	2.09	4.60	1.67	0.42	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	5.96	5.50	5.50	1.38	0.46	0.46	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	8.75	3.70	0.84	0.50	0.34	0.17	0.17	0.00	0.00
Synoviocyte, donor2	11368-117I9	17.43	6.03	10.06	2.85	0.34	0.50	0.50	0.34	0.34
Synoviocyte, donor3	11440-118H9	9.83	7.60	10.50	4.47	0.89	0.22	0.89	0.22	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	6.79	0.71	1.43	1.07	1.07	0.36	0.00	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.41	6.71	2.32	1.16	0.23	0.46	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	18.85	6.38	0.57	1.43	0.50	0.50	0.43	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	4.64	3.87	0.39	0.00	0.00	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	7.44	0.57	1.15	0.00	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	54.13	22.39	13.53	5.66	3.81	2.34	3.08	0.49	0.49
Urethra, donor2	10319-105A4	55.75	23.38	25.18	7.19	0.00	0.00	5.40	1.80	0.00
Urothelial Cells, donor1	11520-119H8	7.97	5.05	1.33	0.80	0.53	0.00	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	8.81	5.21	1.20	0.00	0.00	0.00	0.40	0.00	0.80
Urothelial Cells, donor3	11681-122H7	11.00	5.96	1.15	1.38	0.46	0.92	0.23	0.00	0.46
Urothelial cells, donor0	11216-116B1	15.38	8.47	2.23	1.78	2.01	0.67	0.89	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	83.64	131.69	10.68	6.23	16.91	4.45	10.68	0.00	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	125.81	11.44	7.15	34.31	10.01	8.58	0.00	5.72
Whole blood (ribopure), donor090309, donation3	12181-129A3	76.67	84.20	6.85	2.74	13.01	9.58	4.79	0.00	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	104.33	87.81	3.10	1.72	9.99	6.20	9.30	0.00	2.75
Whole blood (ribopure), donor090325, donation2	12177-128I8	96.45	87.74	3.49	2.32	5.81	5.23	3.49	0.00	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	74.97	129.11	5.21	4.16	15.62	7.29	5.21	0.00	4.16
Whole blood (ribopure), donor090612, donation2	12183-129A5	54.15	140.42	6.42	1.84	15.60	10.10	7.34	0.00	5.51
Whole blood (ribopure), donor090612, donation3	12184-129A6	94.03	65.73	9.13	3.65	14.61	10.95	4.56	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	5.67	4.81	2.22	1.97	0.86	0.74	0.49	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	36.08	6.16	13.20	2.64	3.52	1.76	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	38.55	31.84	6.98	11.17	1.68	1.12	2.51	0.00	0.56
achilles tendon, donor2	10292-104G4	35.13	22.73	4.13	4.13	4.13	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	2.79	3.02	0.46	0.23	0.23	0.70	0.23	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	19.94	15.55	2.49	1.31	1.54	1.42	1.42	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.72	2.45	0.54	0.54	0.54	0.82	0.54	0.00	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	4.78	0.84	0.28	0.28	0.00	0.28	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	4.65	6.98	0.63	0.21	1.27	0.85	1.69	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	3.27	5.72	1.91	0.54	1.36	1.91	0.54	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	11.46	14.54	0.88	1.76	1.32	0.44	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	4.08	14.70	2.04	0.41	1.63	0.41	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	2.72	3.49	1.55	1.55	1.55	1.55	0.00	0.39	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	1.84	4.23	0.37	0.74	0.37	1.10	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	7.80	3.90	0.00	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	22.08	14.64	0.23	0.93	0.70	1.16	1.16	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3.62	8.54	0.52	1.04	1.29	3.11	1.81	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	5.84	7.01	0.00	0.58	1.17	2.05	0.29	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.39	2.79	0.46	0.93	0.46	2.32	0.93	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	4.94	6.17	0.41	0.41	1.65	1.65	0.00	0.00	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.31	2.46	0.31	0.61	0.31	0.31	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	1.71	2.13	0.43	0.85	1.28	0.00	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	2.12	2.43	1.52	0.61	0.91	2.43	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	2.41	1.93	0.24	0.48	0.48	1.44	0.72	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.89	3.34	0.22	0.45	0.00	0.45	0.22	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	5.67	3.00	0.33	0.00	0.00	2.67	0.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	24.16	5.57	9.29	5.57	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	9.04	1.13	0.75	1.51	0.75	1.13	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	4.80	3.49	0.44	0.00	2.18	1.31	0.87	0.00	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	1.87	0.00	3.75	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	68.06	34.15	17.19	14.60	1.65	1.18	1.88	0.24	2.12
adipose tissue, adult, pool1	10010-101C1	32.11	19.70	10.55	4.96	2.02	1.55	1.86	0.47	1.55
adipose, donor1	10184-103D4	8.21	4.69	1.76	2.35	0.59	1.17	0.00	0.00	0.00
adipose, donor2	10185-103D5	18.65	19.87	6.89	4.06	3.24	5.27	1.22	0.41	0.41
adipose, donor3	10186-103D6	28.59	9.26	4.08	5.17	1.36	2.45	0.54	0.27	0.00
adipose, donor4	10187-103D7	118.75	20.80	0.87	5.20	0.87	7.80	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.00	2.84	1.89	0.63	2.21	1.58	1.42	0.47	0.79
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	14.55	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	1.07	1.47	0.00	0.13	0.13	0.13	0.13	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	18.58	11.79	0.36	2.50	1.07	0.00	0.71	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	145.37	31.76	5.56	9.74	1.62	0.00	1.85	0.46	1.39
amniotic membrane cells, donor2	12236-129G4	32.46	14.88	2.70	1.35	1.01	1.01	1.01	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	69.82	37.41	4.12	7.37	0.59	0.00	0.29	0.00	0.29
amygdala - adult, donor10196	10167-103B5	10.67	2.37	10.67	2.37	0.00	2.37	1.19	2.37	0.00
amygdala, adult, donor10252	10151-102I7	17.64	6.08	16.83	2.64	3.65	4.26	0.81	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	8.07	7.10	8.71	1.61	0.32	1.94	0.32	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	24.96	14.26	4.33	4.07	2.67	1.78	2.04	0.13	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
aorta, adult, pool1	10052-101G7	25.11	19.22	27.85	7.06	2.16	0.59	0.78	0.98	0.59
appendix, adult	10189-103D9	38.81	14.75	4.66	2.33	2.33	1.55	2.33	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	5.85	6.19	1.03	3.44	1.38	2.75	1.72	0.00	0.69
artery, adult	10190-103E1	12.23	14.95	8.15	0.00	2.72	0.00	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	30.57	10.72	5.65	4.64	3.19	1.88	2.61	0.29	0.72
b cell line:RPMI1788	10427-106D4	0.59	1.19	0.30	0.30	1.49	0.45	0.59	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	9.43	4.99	0.83	2.50	0.28	0.00	0.55	0.00	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.95	9.92	0.50	1.29	1.49	1.09	0.89	0.00	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	22.26	8.70	8.54	6.03	1.00	1.17	0.50	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.56	2.24	0.56	0.56	1.68	2.24	0.00	0.00	1.12
bladder, adult, pool1	10011-101C2	33.90	22.38	14.34	5.11	3.80	2.82	2.06	1.09	1.09
blood, adult, pool1	10053-101G8	93.01	81.94	4.43	13.29	17.72	8.86	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	25.69	11.13	3.43	2.57	0.00	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	10.80	10.80	7.42	0.00	3.37	0.67	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	9.23	4.10	10.25	3.08	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	10.47	6.24	10.47	3.45	2.34	2.00	0.67	0.78	0.45
brain, fetal, pool1	10085-102B4	5.34	2.67	26.71	2.67	5.34	0.00	2.67	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	21.47	10.24	3.30	5.29	0.99	0.00	0.66	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	49.93	17.35	13.86	8.49	2.12	0.75	0.87	0.00	0.50
breast, adult, donor1	10080-102A8	20.83	13.89	21.47	2.53	2.53	1.89	1.89	0.00	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.65	9.78	5.84	1.65	0.89	1.27	0.51	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.28	20.41	9.90	7.42	2.16	4.02	2.16	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	4.60	1.84	0.23	0.46	0.23	0.00	0.46	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.53	15.98	6.54	3.63	0.97	1.45	0.73	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.00	0.47	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	136.51	44.74	9.08	11.05	5.36	3.06	1.97	0.33	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	5.70	6.65	17.43	6.65	1.90	3.49	0.32	2.22	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	4.53	5.32	1.60	1.86	0.53	0.53	0.80	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	10.36	1.15	9.21	5.76	1.15	3.45	1.15	1.15	1.15
caudate nucleus, adult, donor10252	10164-103B2	10.37	4.69	10.71	2.18	2.18	2.51	0.84	0.67	0.50
caudate nucleus, adult, donor10258	10379-105H1	7.64	1.53	8.41	1.53	0.00	1.53	0.76	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	17.21	5.49	9.52	1.83	1.10	2.20	0.37	1.46	0.37
cerebellum - adult, donor10196	10173-103C2	0.00	2.91	20.39	0.00	0.00	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	12.60	5.34	24.34	4.48	3.20	4.06	0.43	3.84	0.43
cerebellum, adult, pool1	10083-102B2	2.41	3.10	12.76	2.07	2.07	1.03	0.69	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	5.81	7.47	9.13	3.32	0.00	2.49	1.66	3.32	0.00
cerebral meninges, adult	10188-103D8	16.64	5.04	4.79	2.27	1.26	1.01	0.76	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	11.69	3.65	5.85	1.46	0.73	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	4.74	5.46	6.76	3.16	1.15	0.29	0.86	0.14	0.29
cervical cancer cell line:ME-180	10553-107I4	139.37	24.86	13.42	11.43	0.99	0.33	1.33	0.50	0.66
cervix, adult, pool1	10013-101C4	32.76	22.57	13.02	6.30	5.67	1.99	2.62	0.31	1.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.57	5.57	1.67	1.95	0.98	0.42	0.98	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	3.92	1.31	0.00	1.31	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.07	8.20	1.37	1.86	1.24	1.12	1.74	0.00	0.62
choriocarcinoma cell line:SCH	10785-110H2	16.88	13.31	0.86	0.99	1.60	0.62	1.48	0.00	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	3.56	5.69	0.47	1.42	1.42	1.19	0.95	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	50.15	15.96	1.71	3.70	2.56	0.57	1.99	0.00	0.85
chorionic membrane cells, donor2	12239-129G7	10.84	6.26	1.49	2.59	0.80	0.30	0.70	0.10	0.40
chorionic membrane cells, donor3	12240-129G8	8.79	7.69	1.65	3.85	2.75	0.00	2.20	0.00	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	6.34	4.99	1.92	1.54	0.58	0.96	0.00	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.17	21.75	4.43	6.97	1.48	1.27	0.84	0.00	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.33	23.11	0.77	1.28	1.54	2.57	1.28	0.00	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	20.32	30.23	1.45	3.39	2.66	3.39	2.66	0.48	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.94	21.38	1.02	2.85	3.05	3.05	3.26	0.00	2.04
chronic myelogenous leukemia cell line:K562	10454-106G4	80.09	55.36	1.77	3.83	1.47	2.94	2.36	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.52	27.63	7.04	4.95	2.87	2.35	2.61	0.52	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	2.51	2.97	0.69	0.91	1.37	0.69	1.60	0.00	1.60
clear cell carcinoma cell line:TEN	10636-108I6	21.51	6.77	1.39	2.08	0.69	0.69	0.35	0.00	0.69
colon carcinoma cell line:CACO-2	10513-107D9	13.55	8.60	0.55	0.92	0.73	0.55	1.65	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	19.76	15.58	7.60	7.60	3.80	3.04	3.80	0.38	0.76
colon, adult, donor1	10082-102B1	74.97	24.99	10.71	8.33	0.00	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	70.03	23.15	13.04	7.64	3.88	3.53	1.53	0.71	1.06
colon, fetal, donor1	10070-101I7	144.61	38.32	24.72	10.51	2.47	6.18	4.94	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	87.09	27.50	0.00	18.33	0.00	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	48.02	7.22	2.12	2.97	0.00	1.27	0.85	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	19.77	6.79	1.21	2.26	0.00	0.30	0.15	0.45	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	20.31	5.64	0.99	1.69	0.14	0.85	0.28	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	34.61	13.82	33.17	9.51	6.52	4.64	1.22	2.65	0.88
cruciate ligament, donor2	10295-104G7	44.58	24.31	12.97	3.24	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	14.45	15.25	16.05	5.62	3.21	0.00	0.00	0.80	0.80
diencephalon, adult	10193-103E4	11.04	5.28	16.56	4.32	0.72	0.96	0.00	2.64	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	77.96	30.26	3.08	3.33	1.54	2.05	2.05	0.00	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.00	10.59	2.89	3.37	0.24	0.96	0.24	0.00	0.00
ductus deferens, adult	10196-103E7	12.46	7.48	14.45	2.49	1.99	1.00	1.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	40.33	28.80	23.04	8.64	1.44	4.32	0.00	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	43.40	33.10	12.51	8.09	0.74	1.47	1.47	0.00	1.47
dura mater, adult, donor1	10041-101F5	83.33	54.26	21.80	13.71	7.85	2.56	3.80	1.40	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.77	1.55	1.33	2.22	0.00	0.44	0.22	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	11.32	4.59	1.86	1.29	0.29	0.29	0.72	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	27.75	3.08	3.08	1.23	1.23	1.23	0.00	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	17.56	18.77	1.21	2.72	1.82	1.82	1.21	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	35.20	22.23	0.62	2.78	3.09	0.62	0.62	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	44.66	28.90	1.31	6.57	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	4.02	3.69	3.35	1.34	2.01	0.67	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	21.02	13.05	3.81	2.90	3.99	0.91	1.99	0.18	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.71	10.61	1.13	0.48	0.96	0.64	0.64	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	105.60	33.01	3.78	4.89	1.78	0.00	1.22	0.11	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	37.07	19.80	2.86	1.98	3.19	1.21	0.99	0.00	0.99
epididymis, adult	10197-103E8	20.30	17.37	7.95	2.93	1.26	1.05	1.05	0.00	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	17.92	13.48	4.26	4.44	0.71	0.35	0.89	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.83	9.44	2.36	1.57	0.00	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	11.66	6.68	1.70	3.41	0.66	0.00	0.66	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	22.05	8.27	5.81	5.02	0.79	1.38	1.08	0.20	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.44	5.71	1.57	2.58	0.34	0.11	0.45	0.11	0.45
esophagus, adult, pool1	10015-101C6	114.88	19.86	17.41	7.43	2.97	1.38	1.81	0.21	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.19	12.77	12.90	3.63	1.13	0.63	1.00	0.50	0.25
eye - muscle inferior rectus, donor1	10272-104E2	28.97	12.07	12.07	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	21.04	8.42	2.10	2.10	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	23.81	8.93	7.44	2.98	0.00	0.00	1.49	1.49	0.00
eye - muscle superior, donor2	10297-104G9	25.22	11.46	16.05	0.00	1.15	1.15	1.15	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	16.03	13.12	5.83	4.37	0.00	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.41	9.41	19.07	4.83	3.56	2.29	0.51	0.51	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	5.90	6.28	1.15	1.92	1.54	0.38	0.90	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	1.90	1.90	0.71	0.71	0.24	0.24	0.71	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	11.45	6.19	10.79	3.47	2.63	1.60	0.47	2.06	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	66.05	33.63	13.81	11.41	1.50	1.50	0.90	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	23.86	14.63	1.74	1.74	1.37	0.64	2.93	0.00	0.82
gall bladder, adult	10198-103E9	70.02	24.63	28.49	8.93	1.69	2.41	1.21	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	155.69	149.25	2.68	3.22	4.29	4.29	4.29	1.07	2.15
gamma delta positive T cells, donor2	11938-126A3	173.67	149.40	2.99	4.86	4.48	4.48	2.99	0.37	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.23	9.08	4.44	5.28	0.42	0.21	0.63	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.42	23.21	6.58	8.70	0.97	0.39	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	6.23	5.74	1.97	0.66	1.15	0.66	1.64	0.33	0.66
gastric cancer cell line:GSS	10560-108A2	11.90	21.97	1.83	0.92	0.00	0.00	2.75	0.00	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	20.79	7.54	2.06	2.06	0.69	0.46	0.23	0.23	0.91
giant cell carcinoma cell line:LU65	10487-107B1	7.80	10.56	5.39	3.67	1.38	0.57	0.69	0.23	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	9.10	10.36	0.84	1.26	1.12	0.28	0.84	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	40.66	22.70	2.49	3.24	1.00	0.75	1.25	0.25	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	8.13	7.07	0.84	0.53	0.42	0.32	1.16	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	8.01	9.13	2.53	1.83	0.56	0.84	1.12	0.14	0.42
glioblastoma cell line:T98G	10485-107A8	7.62	6.51	0.99	1.43	0.55	0.22	1.21	0.00	0.11
glioma cell line:GI-1	10413-106B8	21.67	10.25	4.10	1.76	1.17	1.46	1.76	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	9.48	9.48	24.05	8.02	0.73	2.92	0.00	2.19	0.00
globus pallidus, adult, donor10252	10161-103A8	29.29	8.79	30.02	8.30	3.66	2.44	1.22	2.44	0.00
globus pallidus, adult, donor10258	10367-105F7	13.69	6.85	13.69	8.22	0.00	2.74	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	11.72	5.86	7.99	0.53	2.13	1.60	0.00	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	75.86	53.84	4.89	17.13	7.34	2.45	2.45	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	21.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	31.36	10.45	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.44	7.36	3.20	2.24	0.64	0.00	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	6.89	5.97	1.38	3.21	0.46	0.92	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	2.74	4.57	2.29	3.20	0.46	0.91	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	4.51	5.80	0.64	2.58	0.64	1.93	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	10.06	1.44	0.00	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.86	3.43	0.69	2.74	0.69	1.37	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	8.83	4.41	6.62	3.31	0.00	1.10	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.29	0.29	0.00	0.00	0.29	0.29	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	32.89	13.75	10.76	4.19	0.60	0.30	1.49	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	24.58	14.38	15.43	2.35	1.83	0.78	0.26	1.31	1.05
heart - tricuspid valve, adult	10207-103F9	34.14	19.98	7.49	2.50	3.33	1.67	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	15.30	8.16	3.67	1.84	2.65	1.84	0.82	0.00	1.22
heart, adult, diseased, donor1	10051-101G6	11.92	7.66	2.98	2.13	0.85	0.85	0.43	0.00	0.43
heart, adult, pool1	10016-101C7	18.17	9.43	5.75	1.15	3.22	2.07	0.69	0.00	0.92
heart, fetal, pool1	10046-101G1	38.71	21.46	16.22	5.54	5.13	2.57	2.46	0.51	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.44	5.86	5.55	2.47	0.00	0.00	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	20.22	3.57	7.14	1.19	1.19	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	53.81	25.30	4.42	8.07	2.87	2.76	0.88	0.11	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	57.90	21.60	4.25	7.16	2.18	2.06	2.31	0.00	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	62.75	27.08	5.66	8.89	2.32	2.83	1.82	0.30	1.41
hepatoma cell line:Li-7	10484-107A7	31.03	7.90	9.79	7.12	1.11	1.11	0.56	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.10	0.10	0.10	0.00	0.00	0.10	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	7.57	3.79	11.36	2.84	2.84	1.89	0.95	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	17.55	6.12	23.88	5.71	4.49	4.08	0.20	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	2.99	4.98	5.48	1.00	0.50	1.49	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	5.99	7.05	4.58	0.70	0.35	1.06	0.35	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.10	3.66	1.83	0.00	1.22	0.00	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.69	3.93	3.93	2.75	0.00	1.77	0.20	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.06	2.54	2.03	0.76	0.25	1.27	0.51	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	3.38	1.69	4.51	0.56	1.69	0.56	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	6.97	4.13	2.84	4.13	1.29	0.77	1.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	7.21	7.21	1.52	1.52	1.14	1.14	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	22.77	13.43	3.80	1.75	0.88	1.46	0.58	0.58	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	24.34	9.26	5.60	6.25	0.86	3.66	0.86	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	25.44	15.01	3.34	1.67	0.00	0.83	1.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.73	7.58	3.55	1.89	0.71	1.18	0.24	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.02	8.36	2.73	3.38	3.05	1.93	0.48	0.16	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.16	8.75	3.37	1.35	1.35	1.35	0.67	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	5.16	3.29	2.66	3.60	0.47	1.25	0.31	0.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.86	2.95	3.93	2.95	0.98	1.97	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	4.36	1.75	0.00	0.00	1.75	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	14.51	7.25	1.72	3.25	0.57	2.67	0.95	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.85	7.41	3.05	4.80	0.87	2.18	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	12.99	7.00	1.00	3.00	2.00	0.50	0.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	20.16	16.20	5.65	5.46	2.07	2.45	3.20	0.57	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	15.01	17.28	6.37	6.82	2.73	3.18	2.73	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.29	16.29	3.13	2.19	2.51	3.76	0.94	0.31	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	4.74	5.23	2.94	2.12	1.14	1.96	0.65	0.33	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	3.19	5.52	1.45	1.74	0.87	2.32	0.87	0.29	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	3.89	6.88	3.29	0.60	1.49	1.49	1.49	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	4.25	2.22	3.14	2.03	0.74	1.48	0.00	0.37	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.56	2.57	2.85	3.42	0.57	1.43	0.00	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.17	3.27	1.63	2.04	0.41	1.22	0.41	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.15	4.22	3.17	2.46	1.06	0.35	0.00	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	8.24	2.85	0.95	3.17	0.32	0.95	0.00	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.87	2.42	0.30	1.21	0.30	1.21	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	12.93	5.69	2.59	5.69	1.55	4.14	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.97	7.31	3.32	3.32	0.66	1.33	0.66	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.18	8.21	1.54	1.03	0.26	1.03	1.54	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.97	3.83	3.07	1.79	0.77	1.28	1.02	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	6.82	10.60	2.27	0.00	1.51	0.76	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	10.42	5.04	1.01	1.01	1.01	0.67	1.34	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	5.31	1.69	3.14	3.62	0.24	0.48	0.24	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.68	4.46	0.89	0.45	0.00	2.23	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	10.73	2.44	1.46	2.44	0.49	1.46	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	12.22	2.75	2.75	1.83	0.31	1.22	0.31	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	19.52	3.25	6.51	3.25	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	7.94	2.65	0.00	2.32	0.99	0.66	0.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	19.70	9.30	2.74	7.11	0.55	1.09	2.19	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	23.88	13.75	4.34	2.17	1.09	1.09	2.17	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	14.23	6.41	2.85	1.42	0.71	1.78	1.07	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	3.58	2.39	2.39	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	14.08	7.04	2.98	2.44	1.35	1.90	1.08	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	7.81	4.85	2.42	1.35	0.27	1.62	0.54	0.00	0.00
immature langerhans cells, donor1	11904-125F5	8.23	2.18	0.24	0.97	0.24	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	97.43	21.39	3.96	4.75	0.00	0.79	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	10.32	5.77	11.26	2.37	2.08	1.70	0.85	1.51	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	70.23	23.09	7.48	13.33	0.65	0.33	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	25.93	9.11	5.21	4.41	1.80	1.20	0.50	0.00	0.40
kidney, fetal, pool1	10045-101F9	30.77	20.87	9.55	6.79	4.53	3.54	2.19	0.21	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	8.10	7.10	1.28	0.99	0.85	0.57	0.71	0.00	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.29	5.81	1.94	2.07	0.00	0.28	0.41	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	18.35	15.60	2.20	2.94	1.47	0.37	0.73	0.00	1.47
left atrium, adult, donor1	10079-102A7	13.62	11.44	6.54	4.90	2.72	0.00	1.63	0.00	0.00
left ventricle, adult, donor1	10078-102A6	6.07	12.64	9.10	2.02	1.52	1.01	1.52	0.00	1.01
leiomyoblastoma cell line:G-402	10721-110A1	0.27	0.00	0.27	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	8.62	1.80	1.44	0.36	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	1.63	1.09	2.17	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	7.77	1.94	1.94	0.73	0.49	0.00	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	7.32	6.27	0.00	2.09	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.47	14.64	9.33	5.90	3.42	1.42	0.83	0.12	0.71
liposarcoma cell line:KMLS-1	10782-110G8	6.72	4.06	1.87	1.41	1.09	0.47	0.31	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	5.97	6.46	1.83	2.19	1.22	0.97	0.49	0.12	0.37
liver, adult, pool1	10018-101C9	24.80	11.02	9.24	2.76	1.94	0.32	0.32	0.32	0.16
liver, fetal, pool1	10086-102B5	46.09	30.10	8.47	0.94	0.00	0.00	0.94	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	12.10	6.85	17.94	5.54	1.75	2.62	0.73	1.60	0.44
locus coeruleus, adult, donor10252	10165-103B3	13.66	5.17	14.03	3.14	2.03	3.14	0.37	0.92	0.00
locus coeruleus, adult, donor10258	10375-105G6	4.51	2.26	17.21	2.26	0.85	1.41	0.00	2.26	0.28
locus coeruleus, newborn, donor10223	10362-105F2	10.94	4.21	2.52	0.42	0.84	1.26	0.42	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	10.66	5.81	1.94	2.21	0.83	0.55	0.42	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	23.44	21.37	4.14	9.65	2.76	0.69	0.69	0.69	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.41	15.42	1.58	4.61	2.11	0.92	1.32	0.00	0.92
lung, adult, pool1	10019-101D1	34.02	20.67	6.97	6.02	5.43	2.24	2.13	0.35	1.18
lung, fetal, donor1	10068-101I5	58.22	78.77	14.56	10.85	7.14	3.71	8.28	0.57	2.28
lung, right lower lobe, adult, donor1	10075-102A3	38.95	25.66	16.50	4.58	3.21	1.37	1.37	0.46	0.92
lymph node, adult, donor1	10077-102A5	17.04	15.15	5.21	3.31	3.31	0.95	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	1.53	1.97	1.10	2.19	1.75	2.85	1.10	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	70.51	52.67	8.49	6.80	1.70	1.70	2.55	0.00	0.85
mature adipocyte, donor1	12231-129F8	27.97	8.44	14.21	7.55	1.33	0.44	0.00	0.89	0.00
mature adipocyte, donor2	12232-129F9	26.98	11.00	10.58	8.30	0.83	1.25	0.42	0.62	0.83
mature adipocyte, donor3	12233-129G1	14.70	6.16	10.90	4.50	0.95	0.24	0.24	0.24	0.71
mature adipocyte, donor4	12234-129G2	15.53	8.42	11.32	6.05	0.79	0.79	1.32	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	50.27	20.73	12.39	13.34	3.34	2.62	1.67	0.00	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	3.38	2.26	5.64	1.13	1.13	0.00	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	18.39	5.33	18.02	3.13	2.21	3.13	0.55	1.29	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	3.81	1.91	8.26	2.54	0.64	1.59	0.64	0.95	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	7.68	2.13	2.99	0.43	0.85	0.00	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	5.91	3.88	9.62	2.87	1.18	1.01	0.34	0.51	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	16.98	5.94	21.01	3.61	2.33	4.67	0.64	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	0.00	11.56	3.85	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	11.49	5.03	5.38	1.44	0.72	0.36	0.00	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	11.03	8.44	18.82	5.84	1.30	0.65	0.65	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	23.07	9.29	20.59	4.18	4.33	4.80	0.77	1.86	0.93
medulla oblongata, adult, pool1	10038-101F2	26.28	11.84	19.43	6.37	3.51	2.78	1.22	2.53	0.33
medulla oblongata, newborn, donor10223	10361-105F1	14.58	6.25	9.72	0.69	1.39	1.74	0.69	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	4.43	4.65	3.32	3.10	0.89	1.99	0.44	0.22	0.89
medulloblastoma cell line:ONS-76	10759-110E3	13.33	7.83	2.93	1.10	1.10	0.61	0.98	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	3.74	5.89	1.58	1.72	1.29	1.01	1.15	0.00	0.43
melanoma cell line:G-361	10465-106H6	5.43	4.89	3.26	1.36	0.00	1.36	0.27	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	13.21	6.33	2.53	1.99	0.90	0.54	0.36	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.88	2.64	0.88	0.00	0.00	2.64	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	12.18	5.96	2.85	2.59	1.56	1.04	0.52	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.84	4.76	2.45	1.38	0.46	0.00	0.46	0.00	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	3.82	4.91	2.91	2.18	0.36	0.18	0.36	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.14	4.14	2.90	0.41	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	2.11	2.25	2.25	2.25	0.42	0.28	0.70	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	2.31	2.89	2.31	2.70	0.77	0.39	0.00	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.25	4.86	4.16	0.69	0.69	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.15	3.78	2.92	0.86	0.34	0.17	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	8.51	4.26	3.45	3.34	0.58	0.69	0.46	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	7.69	5.97	3.05	3.98	0.80	0.13	0.40	0.00	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.48	6.75	2.84	1.49	0.68	0.00	0.14	0.00	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.25	6.12	1.99	2.13	0.14	0.28	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.92	5.60	1.98	0.33	0.66	0.33	1.65	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.86	4.57	1.25	2.21	0.42	0.14	0.55	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	7.33	7.33	3.14	2.09	0.35	0.70	0.70	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	1.84	4.08	1.22	0.61	0.61	0.41	0.20	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	6.11	3.95	1.44	1.08	0.72	0.00	0.72	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	7.97	5.90	2.90	2.17	0.31	0.10	0.52	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.98	4.33	1.60	1.37	0.23	0.23	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.33	9.23	1.26	2.52	0.42	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	8.07	5.98	3.29	2.84	0.30	0.60	0.30	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	9.54	5.51	3.50	3.94	0.44	0.44	0.44	0.09	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	8.10	6.63	2.95	1.47	0.37	0.37	0.37	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.87	3.15	0.29	1.43	0.29	0.57	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	4.21	5.47	0.84	0.84	0.42	0.00	1.26	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	9.13	4.11	6.39	2.74	0.00	0.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.93	6.65	6.65	1.79	0.51	0.26	0.26	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.20	9.16	7.85	2.62	0.26	0.79	0.79	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.41	7.09	7.09	2.46	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.30	8.24	4.47	2.82	0.94	0.94	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.92	6.77	7.45	1.69	1.02	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.08	5.50	4.32	2.36	0.00	1.18	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	6.02	5.10	1.39	0.93	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	19.61	7.50	3.46	0.87	0.87	0.58	1.15	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.42	6.92	5.35	3.12	1.12	0.89	0.22	0.22	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.82	9.37	6.01	0.96	0.24	0.24	0.48	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	15.40	5.87	4.40	0.73	2.93	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.10	7.38	7.72	1.34	0.67	0.67	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	14.74	6.55	4.50	2.46	0.41	0.82	0.00	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	10.74	6.87	2.58	0.43	0.43	0.00	0.00	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	8.20	5.47	0.00	0.00	0.00	0.00	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	8.77	5.52	1.95	0.32	0.00	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	7.27	4.36	0.00	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.66	5.86	4.80	0.00	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	4.91	2.45	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	8.55	5.44	2.33	0.00	0.39	0.00	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20	2.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	5.96	5.96	1.99	0.00	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	9.53	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	2.96	4.74	0.59	0.00	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	3.66	9.75	0.00	1.22	0.00	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.23	3.80	0.00	0.00	0.00	0.63	0.00	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	8.97	4.14	4.48	0.69	0.00	0.34	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	2.15	6.45	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.89	2.85	4.89	1.22	0.41	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	4.77	0.00	3.18	0.00	2.38	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	4.13	2.95	2.36	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.48	3.12	9.66	4.05	0.31	0.00	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	2.67	9.36	4.01	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	8.28	4.73	0.00	0.00	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	7.70	7.70	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	25.47	3.44	7.57	3.44	0.69	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	25.73	6.43	9.40	3.46	0.49	0.49	0.49	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	6.73	11.22	4.49	0.00	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	6.36	10.81	5.09	0.00	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	14.10	4.84	4.43	2.01	0.40	0.40	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	17.44	2.18	0.00	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	3.80	5.07	2.53	0.00	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	7.28	3.03	4.86	2.43	0.00	0.00	1.21	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	2.47	9.06	4.12	0.00	1.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	17.86	6.15	10.12	2.78	0.40	0.20	0.20	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.73	4.22	8.76	4.22	0.32	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	7.13	11.20	2.04	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	6.96	5.42	5.42	0.77	0.00	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	23.62	26.22	4.49	3.78	4.02	1.42	2.36	0.00	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.45	6.72	5.33	3.48	0.46	0.00	0.23	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	8.55	0.00	4.27	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.71	3.29	1.23	0.82	0.10	0.10	0.10	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	7.72	4.54	0.45	0.00	0.45	0.68	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	5.62	3.18	1.22	0.24	0.49	0.98	0.00	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	5.09	5.31	0.22	0.00	1.11	0.22	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	9.99	4.73	2.10	0.53	1.05	0.53	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	5.28	4.60	2.21	0.68	0.68	0.68	0.17	0.00	0.51
mesothelioma cell line:Mero-84	10855-111F9	28.06	7.33	2.02	0.76	0.25	0.00	0.00	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.25	5.38	2.69	1.04	0.83	0.41	0.41	0.00	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	6.29	3.98	1.16	0.83	0.66	0.66	0.33	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	7.42	7.78	1.81	0.90	0.00	0.00	0.90	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	11.79	8.54	3.76	1.88	1.37	0.68	0.17	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	6.87	6.11	1.78	2.04	0.25	0.51	0.00	0.00	0.51
mesothelioma cell line:No36	10857-111G2	1.30	1.96	0.98	0.65	0.00	0.33	0.33	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	7.32	4.34	1.63	0.00	0.27	0.27	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	24.95	17.27	0.58	0.77	0.38	0.96	0.96	0.00	1.34
migratory langerhans cells, donor2	11902-125F3	5.37	6.47	0.24	0.24	0.61	0.37	0.37	0.00	0.73
migratory langerhans cells, donor3	11903-125F4	6.64	6.28	0.54	0.54	1.26	0.90	0.90	0.00	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.53	3.92	1.31	1.31	0.33	0.33	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	0.21	0.64	1.48	0.64	0.21	0.00	0.42	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.29	24.65	3.92	5.07	2.07	2.76	0.69	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.76	0.19	0.00	0.38	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	5.91	6.47	0.92	3.51	1.11	0.37	0.55	0.18	0.74
myeloma cell line:PCM6	10474-106I6	30.84	13.84	3.56	2.17	4.55	6.33	0.59	0.00	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	7.61	7.10	2.03	1.52	0.51	0.51	2.03	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	5.30	7.06	4.71	3.33	1.57	0.39	1.57	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	37.33	16.05	4.01	4.23	0.78	0.56	1.00	0.22	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.90	16.18	2.79	2.79	1.18	0.37	0.51	0.15	0.37
nasal epithelial cells, donor2	12227-129F4	77.83	23.74	4.97	6.62	0.55	4.42	1.66	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	16.33	11.04	1.84	4.37	1.84	2.53	1.61	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	8.04	4.86	4.68	2.62	0.37	0.56	0.37	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	15.61	11.81	11.18	7.17	2.11	5.90	1.27	0.63	0.42
neuroblastoma cell line:NH-12	10555-107I6	8.94	8.94	5.40	4.47	2.05	1.86	1.30	0.56	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	62.39	32.26	17.08	11.39	4.27	4.74	2.85	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	19.48	10.93	6.65	6.18	1.74	1.58	0.48	0.16	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	21.13	10.87	5.03	3.62	1.61	1.21	1.41	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	12.72	3.18	5.09	0.00	0.00	0.64	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	13.31	5.32	4.52	1.60	0.53	0.53	0.53	0.00	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	13.28	0.00	0.00	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	28.41	0.00	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1.18	1.18	0.00	0.68	0.85	0.34	1.18	0.00	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	7.20	1.60	0.80	1.60	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.07	8.98	5.13	4.17	0.32	0.00	0.32	0.00	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.36	3.15	1.05	1.31	0.53	0.26	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	12.75	6.84	15.84	3.94	1.50	1.78	0.66	1.31	0.37
occipital cortex - adult, donor10196	10172-103C1	4.12	4.12	10.30	2.06	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	24.15	8.59	27.64	5.37	2.95	5.64	0.81	0.81	0.81
occipital cortex, newborn, donor10223	10355-105E4	11.28	4.37	7.28	1.82	0.00	0.73	0.00	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	6.30	3.94	18.37	5.51	2.10	1.05	0.26	2.62	0.26
occipital lobe, fetal, donor1	10073-102A1	9.44	6.44	28.32	9.44	3.00	3.00	0.86	1.29	1.29
occipital pole, adult, pool1	10036-101E9	8.75	3.07	10.01	4.02	1.42	1.02	0.55	1.10	0.16
olfactory region, adult	10195-103E6	5.54	3.44	12.61	3.25	2.67	1.34	0.00	1.91	0.19
optic nerve, donor1	10277-104E7	34.02	14.01	38.02	12.01	0.00	0.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	72.90	20.50	6.26	6.26	1.25	1.48	0.57	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.93	12.23	4.12	4.40	0.96	0.41	0.41	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	27.26	15.58	3.05	2.03	0.68	0.51	0.51	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	11.67	12.47	2.08	2.19	1.50	0.92	1.73	0.23	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	14.40	11.46	2.94	0.88	0.59	0.88	0.29	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	51.39	23.36	7.47	1.87	1.87	0.93	3.74	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	21.21	7.00	4.45	3.18	0.21	0.42	0.85	0.21	0.00
ovary, adult, pool1	10020-101D2	42.98	23.93	30.66	9.43	5.85	4.54	2.18	1.05	1.57
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	18.88	8.98	2.93	4.95	1.47	0.92	0.37	0.18	1.47
pancreas, adult, donor1	10049-101G4	6.58	6.58	20.69	4.70	1.88	1.88	0.94	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	13.42	11.74	2.52	2.24	0.56	0.84	0.56	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	14.48	11.41	1.36	1.19	0.17	0.17	0.34	0.00	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	70.04	38.91	1.99	4.31	2.32	1.82	3.31	0.00	0.66
paracentral gyrus, adult, pool1	10035-101E8	9.61	5.77	12.08	4.67	2.84	1.46	0.46	0.82	0.00
parietal cortex, adult, donor10258	10373-105G4	22.75	5.87	4.40	0.73	1.47	2.20	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	4.70	1.88	13.17	0.00	1.88	2.82	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	11.69	4.56	11.40	1.43	0.86	1.43	0.29	0.86	0.86
parietal lobe, adult, pool1	10034-101E7	9.08	3.88	14.80	2.64	2.38	1.76	0.35	0.70	0.09
parietal lobe, fetal, donor1	10072-101I9	8.73	9.70	28.13	2.91	0.97	2.91	1.94	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	11.22	4.49	4.86	0.37	0.37	1.50	0.00	0.37	0.00
parotid gland, adult	10199-103F1	11.10	11.72	9.87	1.85	1.23	1.23	1.23	1.23	0.62
penis, adult	10200-103F2	29.54	22.56	13.43	4.30	2.69	1.07	1.07	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	11.16	11.34	13.57	3.35	1.30	2.60	0.74	2.79	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	46.04	18.94	10.20	9.76	1.31	1.75	0.87	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	11.61	2.58	4.52	5.81	2.58	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	10.07	8.29	10.66	10.66	4.74	4.15	1.18	0.59	0.59
pineal gland, adult, donor10258	10377-105G8	4.39	3.14	8.78	3.76	0.63	1.25	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	23.27	16.19	11.13	7.08	2.02	7.08	1.01	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	20.33	10.42	26.58	7.82	5.73	5.73	0.52	2.08	2.61
pituitary gland, adult, donor10258	10378-105G9	11.92	5.11	5.96	4.26	0.85	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	36.98	17.74	2.58	3.01	2.69	1.18	1.72	0.22	1.40
plasma cell leukemia cell line:ARH-77	10840-111E3	0.79	0.13	0.13	0.00	0.13	0.13	0.13	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	17.43	10.12	1.87	3.89	0.93	0.16	0.78	0.16	0.31
pons, adult, pool1	10033-101E6	18.93	6.28	14.20	4.82	2.67	1.46	1.03	1.29	0.17
postcentral gyrus, adult, pool1	10032-101E5	9.41	5.32	10.37	4.01	2.53	1.39	0.52	1.66	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	20.91	4.18	8.37	2.09	2.09	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	22.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	0.00	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	11.65	8.16	1.02	1.31	1.75	0.29	0.44	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	14.16	9.44	2.00	2.00	0.91	0.18	0.54	0.00	0.18
prostate, adult, pool1	10022-101D4	28.39	13.88	14.96	4.44	3.26	1.81	0.91	0.63	0.63
putamen, adult, donor10196	10176-103C5	6.85	2.83	7.79	2.60	1.65	1.65	0.71	0.47	0.47
putamen, adult, donor10252	10152-102I8	11.76	5.88	7.84	0.00	0.00	0.00	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	3.28	5.46	8.74	1.09	1.09	1.09	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	3.38	4.59	6.52	0.97	2.17	0.97	0.24	1.45	0.24
putamen, newborn, donor10223	10365-105F5	9.75	2.25	2.25	2.25	0.00	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	55.86	27.93	6.11	5.53	2.04	2.62	2.62	0.00	0.58
rectum, fetal, donor1	10067-101I4	83.46	29.21	48.68	23.65	8.35	1.39	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.15	5.72	2.12	1.27	1.27	0.21	0.42	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	4.56	9.53	0.00	2.49	2.49	2.49	2.49	0.00	0.83
retina, adult, pool1	10030-101E3	16.90	12.72	10.93	6.36	4.77	1.99	1.89	0.89	0.60
retinoblastoma cell line:Y79	10475-106I7	2.34	4.16	1.04	0.52	0.52	0.00	1.04	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	10.57	7.13	2.09	1.84	0.98	0.86	0.12	0.00	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	40.21	28.40	11.25	10.69	3.09	3.09	2.25	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	17.43	6.82	6.82	3.79	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	14.73	5.99	7.61	3.24	0.81	0.32	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	36.35	14.32	12.25	5.65	1.24	1.10	0.28	0.28	0.28
salivary acinar cells, donor3	11773-123I9	74.81	22.51	23.83	11.92	0.66	0.66	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	8.01	10.30	13.73	2.29	0.57	1.72	1.72	0.57	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.02	10.03	2.95	1.52	2.70	1.43	2.02	0.08	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	10.11	10.34	2.35	2.23	2.23	1.88	1.18	0.12	0.35
seminal vesicle, adult	10201-103F3	24.34	8.47	17.99	5.29	4.23	4.23	1.06	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	5.10	7.04	0.00	1.70	0.73	0.49	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	6.29	6.79	1.51	1.01	1.26	0.25	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	6.02	8.03	1.00	0.00	2.01	0.00	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	28.48	17.46	2.55	3.09	2.15	1.48	1.07	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	52.50	19.12	5.97	4.75	1.33	0.66	1.88	0.00	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	61.16	15.35	6.97	8.90	0.65	0.00	0.65	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	8.51	9.22	7.80	0.71	0.00	0.71	0.00	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	12.71	12.23	10.79	3.12	1.92	0.84	1.20	0.36	0.96
skeletal muscle, fetal, donor1	10066-101I3	14.07	21.11	22.11	2.01	2.01	1.01	3.02	1.01	1.01
skin, adult, donor1	10074-102A2	94.99	33.93	54.28	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	77.64	34.72	31.56	14.52	3.16	3.79	0.63	3.79	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.01	13.34	4.00	3.00	1.00	4.00	2.00	0.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.20	6.62	4.73	2.21	0.95	0.95	1.26	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.39	0.96	0.00	0.39	1.54	1.73	0.19	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	35.93	9.72	5.60	8.57	1.48	0.00	1.81	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.48	0.48	0.00	0.00	0.00	0.32	0.32	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	43.80	20.92	11.55	10.90	4.58	2.83	0.87	0.44	0.22
small intestine, adult, pool1	10024-101D6	116.34	31.65	11.23	9.67	3.94	2.03	2.03	0.48	0.72
small intestine, fetal, donor1	10064-101I1	42.75	24.32	11.79	10.32	3.44	0.98	0.98	0.49	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	16.41	8.72	8.21	2.05	0.00	0.51	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	14.73	9.56	18.87	6.20	4.91	1.29	0.26	1.03	1.29
somatostatinoma cell line:QGP-1	10781-110G7	41.81	12.60	18.49	16.35	1.88	4.56	0.27	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	13.76	6.65	22.02	8.95	2.06	2.75	0.69	2.52	0.00
spinal cord, adult, donor10252	10159-103A6	26.42	6.31	29.18	13.41	3.55	1.18	1.18	2.76	0.79
spinal cord, adult, donor10258	10369-105F9	6.92	2.08	8.99	2.77	0.69	2.08	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	26.83	5.49	25.00	9.76	4.27	1.83	1.22	1.22	0.00
spinal cord, newborn, donor10223	10359-105E8	20.21	5.97	6.89	1.38	0.92	1.38	0.00	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	16.73	7.47	5.68	2.09	0.75	0.30	0.45	0.00	0.15
spleen, adult, pool1	10025-101D7	37.23	18.50	4.74	3.08	5.62	2.20	2.97	0.00	1.54
spleen, fetal, pool1	10044-101F8	70.56	42.83	8.66	4.29	6.59	3.73	3.42	0.24	1.59
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.10	0.00	0.00	0.00	0.00	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	66.08	19.18	5.70	6.65	1.33	0.76	1.14	0.00	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.51	18.17	2.10	1.75	1.75	1.05	2.45	0.00	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	6.65	9.38	1.56	1.17	0.00	1.56	0.39	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	21.61	11.93	6.87	5.97	2.48	1.91	0.56	0.34	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	16.94	6.78	2.12	1.69	0.42	0.42	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	10.58	8.88	0.00	0.85	2.96	0.42	1.27	0.00	1.27
stomach, fetal, donor1	10062-101H8	211.46	53.40	33.11	32.04	5.34	1.07	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	13.67	9.68	7.98	1.71	1.71	1.71	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	26.17	6.44	27.21	3.32	1.87	3.74	0.83	1.87	0.83
substantia nigra, adult, donor10258	10371-105G2	6.21	7.24	10.86	4.14	2.07	2.59	0.00	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	15.54	8.48	12.01	0.71	0.71	2.12	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	11.46	7.11	4.36	2.98	1.60	1.38	0.92	0.69	0.46
temporal lobe, adult, pool1	10031-101E4	10.85	5.93	10.94	2.71	1.86	1.53	0.34	1.27	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.99	7.83	17.81	4.27	2.85	2.85	1.42	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	4.83	6.15	11.43	1.32	1.32	1.76	0.00	1.32	0.00
tenocyte, donor1	11763-123H8	8.03	5.24	5.59	3.14	0.35	0.35	0.70	0.00	0.00
tenocyte, donor2	11765-123I1	8.39	4.96	8.77	2.67	0.00	1.14	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	14.46	7.78	10.01	2.22	0.74	0.74	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	6.80	4.42	2.04	1.36	0.51	0.85	0.51	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	15.57	10.33	0.92	2.00	2.47	0.77	0.77	0.00	0.77
teratocarcinoma cell line:PA-1	10807-111A6	10.38	6.35	3.41	2.63	1.55	1.70	0.46	0.15	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	11.30	6.35	2.03	3.43	0.51	0.89	0.25	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	4.92	4.54	2.27	1.89	0.00	2.65	1.13	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.67	9.38	8.29	7.63	0.22	0.55	0.55	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	2.93	7.49	0.98	0.33	1.30	1.30	1.95	0.00	0.33
testis, adult, pool1	10026-101D8	14.92	12.13	8.05	3.87	3.22	2.25	2.25	0.21	1.18
testis, adult, pool2	10096-102C6	9.47	7.67	2.71	1.80	2.71	2.26	0.00	0.00	0.45
thalamus - adult, donor10196	10168-103B6	17.66	9.94	17.66	11.04	3.31	3.31	1.10	2.21	0.00
thalamus, adult, donor10252	10154-103A1	28.44	7.81	32.35	7.50	2.97	4.38	0.94	1.72	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	6.16	7.70	1.54	1.54	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.08	2.80	10.21	1.98	0.82	0.99	0.33	1.81	0.00
thalamus, newborn, donor10223	10366-105F6	4.60	2.30	3.45	0.58	0.00	0.00	0.00	0.00	0.00
throat, adult	10209-103G2	72.90	26.71	13.48	3.99	1.75	2.25	1.00	0.75	1.00
throat, fetal, donor1	10061-101H7	31.99	16.76	23.77	10.66	3.66	1.83	0.91	0.91	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	0.60	3.58	2.78	0.79	0.20	0.60	0.40	0.00	0.00
thymus, adult, pool1	10027-101D9	9.84	8.65	1.19	1.19	2.58	1.19	0.99	0.10	0.50
thymus, fetal, pool1	10043-101F7	25.46	14.75	5.71	3.95	4.05	3.12	1.87	0.21	1.66
thyroid carcinoma cell line:KHM-5M	10776-110G2	5.19	5.45	0.27	0.53	0.27	0.53	0.80	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	10.34	7.96	4.47	3.49	0.98	0.84	0.98	0.14	0.84
thyroid, adult, pool1	10028-101E1	24.73	9.33	14.00	5.88	3.64	3.08	1.59	0.65	1.49
thyroid, fetal, donor1	10060-101H6	26.10	11.07	17.40	8.96	2.11	2.11	0.53	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	24.64	30.80	6.16	9.24	3.08	0.00	3.08	0.00
tongue, adult	10203-103F5	49.07	16.28	7.44	3.72	1.16	0.70	0.93	0.47	0.70
tongue, fetal, donor1	10059-101H5	49.26	14.19	16.16	11.82	1.97	0.00	1.58	0.39	1.18
tonsil, adult, pool1	10047-101G2	98.27	28.95	9.52	6.11	3.11	1.80	1.30	0.10	1.20
trachea, adult, pool1	10029-101E2	52.51	22.58	7.44	5.40	2.45	0.82	2.04	0.33	1.06
trachea, fetal, donor1	10058-101H4	54.24	19.23	28.85	9.62	1.92	0.77	1.54	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	10.27	3.90	2.13	2.13	1.42	0.00	0.35	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	77.91	18.84	5.17	5.88	1.01	0.51	0.71	0.00	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	14.89	13.01	3.60	2.19	0.94	0.63	1.57	0.00	0.16
tridermal teratoma cell line:HGRT	10694-109G1	19.03	19.03	5.71	1.90	0.00	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.74	17.95	4.66	5.42	0.85	0.08	0.68	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	16.69	14.61	2.09	2.09	4.17	2.09	4.17	0.00	2.09
uterus, adult, pool1	10100-102D1	21.50	33.44	13.99	8.36	5.46	3.41	3.24	0.17	1.37
uterus, fetal, donor1	10055-101H1	33.28	11.77	16.38	6.14	2.56	2.56	3.07	0.00	0.51
vagina, adult	10204-103F6	23.26	14.86	20.03	4.52	5.82	5.82	2.58	1.94	1.29
vein, adult	10191-103E2	19.51	17.54	9.64	1.32	2.41	1.10	0.88	0.66	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.94	5.07	0.27	1.07	0.80	0.80	0.27	0.00	0.00